: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Influenza

Free Subscription

Articles published in Lancet
Retrieve available abstracts of 977 articles:
HTML format

Single Articles

January 2025

MUMFORD L, Hogg R, Taylor A, Lanyon P, et al
Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study.
Lancet. 2025;405:314-328.
PubMed Abstract available

December 2024

DZAU VJ, Laitner MH, Shambaugh EL
Strategic imperatives for health in the USA: a roadmap for the incoming presidential administration.
Lancet. 2024;404:2371-2379.
PubMed Abstract available

The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet. 2024;404:2314-2340.
PubMed Abstract available

October 2024

PAYNE AB, Watts JA, Mitchell PK, Dascomb K, et al
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.
Lancet. 2024;404:1547-1559.
PubMed Abstract available

BRANDA F, Oh J, Acharya KP, Yon DK, et al
Human vaccination for highly pathogenic avian influenza.
Lancet. 2024;404:1518-1519.
PubMed

September 2024

ROMANELLO M, Costello A
The Lancet Countdown on health and climate change: competing interests and optimism bias - Authors' reply.
Lancet. 2024;404:1197-1198.
PubMed

BRINK N, Chersich MF
The Lancet Countdown on health and climate change: competing interests and optimism bias.
Lancet. 2024;404:1196.
PubMed

BUTLER CD, Combs Bowles D, Hanigan IC, Harmer A, et al
The Lancet Countdown on health and climate change: competing interests and optimism bias.
Lancet. 2024;404:1196-1197.
PubMed

ROMANELLO M, Beggs PJ, Cai W, Gordon-Strachan G, et al
The Lancet Countdown on health and climate change: representation matters - Authors' reply.
Lancet. 2024;404:1195-1196.
PubMed

STREET R, Wright CY
The Lancet Countdown on health and climate change: representation matters.
Lancet. 2024;404:1194.
PubMed

HORTON R
Offline: Xenotransplantation-a new era beckons.
Lancet. 2024;404:1181.
PubMed

ELNAKIB S, Aly S, Asi YM, Shawar YR, et al
The humanitarian system: politics can not be avoided.
Lancet. 2024;404:1105-1106.
PubMed

ST LOUIS P, Makali SL, Paul E
Health-care workers in fragile and conflict-ridden contexts.
Lancet. 2024;404:1105.
PubMed

RAUSEI S, Bertolini AG
Cuban doctors cannot be the definitive solution for Italy.
Lancet. 2024;404:1103.
PubMed

YANG X, Zhang Z, Zhang Z
Building safe health-care environments in China: urgent challenges.
Lancet. 2024;404:1101-1102.
PubMed

HWANG TJ, Trinh QD, Sokolov E
Safe and equitable use of clinical decision support systems.
Lancet. 2024;404:1100-1101.
PubMed

HORTON R
Offline: From Wanless to Darzi-don't miss this opportunity (again).
Lancet. 2024;404:1088.
PubMed

MAZUR NI, Caballero MT, Nunes MC
Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies.
Lancet. 2024;404:1143-1156.
PubMed Abstract available

NACHEGA JB, Muyembe-Tamfum JJ, Ntoumi F, Mbala-Kingebeni P, et al
A call for global solidarity and rapid action to control mpox.
Lancet. 2024;404:1099-1100.
PubMed

IMANI-MUSIMWA P, Ververs M
Mpox and breastmilk: for once, can we act in time?
Lancet. 2024 Sep 13:S0140-6736(24)01881-6. doi: 10.1016/S0140-6736(24)01881.
PubMed

PECENKA C, Sparrow E, Feikin DR, Srikantiah P, et al
Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children.
Lancet. 2024 Sep 6:S0140-6736(24)01699-4. doi: 10.1016/S0140-6736(24)01699.
PubMed Abstract available

August 2024

MACNAUGHTON J, Zeiler K
Reimagining illness through post-COVID-19 condition: the need for radically interdisciplinary health research.
Lancet. 2024;404:840-841.
PubMed

ZAROCOSTAS J
Many challenges for WHO-AFRO regional director candidates.
Lancet. 2024;404:736-737.
PubMed

ZHAO Y, Gao Y, Guyatt G, Uyeki TM, et al
Antivirals for post-exposure prophylaxis of influenza: a systematic review and network meta-analysis.
Lancet. 2024;404:764-772.
PubMed Abstract available

GAO Y, Guyatt G, Uyeki TM, Liu M, et al
Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials.
Lancet. 2024;404:753-763.
PubMed Abstract available

HUI DSC
Antiviral treatment and prophylaxis for influenza.
Lancet. 2024;404:726-727.
PubMed

BRANDA F, Ceccarelli G, Ciccozzi M, Scarpa F, et al
Strengthening community resilience: lessons from COVID-19 for mpox prevention.
Lancet. 2024 Aug 22:S0140-6736(24)01752-5. doi: 10.1016/S0140-6736(24)01752.
PubMed

SAMARASEKERA U
Understanding pandemic risks: the WHO Pandemic Hub.
Lancet. 2024;404:420-421.
PubMed

SHAH SA, Robertson C, Sheikh A
Waiting list models must account for departures before treatment - Authors' reply.
Lancet. 2024;404:432-433.
PubMed

WOOD RM
Waiting list models must account for departures before treatment.
Lancet. 2024;404:431-432.
PubMed

O'NEILL D
Continuing challenges to health equity in Ireland.
Lancet. 2024;404:431.
PubMed

BANATVALA JE, Muir P, Irving W, Meader E, et al
The role of the clinical virologist in pandemic responses.
Lancet. 2024;404:430.
PubMed

GARAY J, Kateeb E, Zeballos D, Souza LE, et al
Inequity in sustainable health today.
Lancet. 2024;404:429-430.
PubMed

GREEN A
Evelyn Fox Keller.
Lancet. 2024;404:426.
PubMed

July 2024

GREENHALGH T, Sivan M, Perlowski A, Nikolich JZ, et al
Long COVID: a clinical update.
Lancet. 2024 Jul 31:S0140-6736(24)01136-X. doi: 10.1016/S0140-6736(24)01136.
PubMed Abstract available

June 2024

SAMARASEKERA U
No parties meeting the challenge on health in the UK.
Lancet. 2024;403:2769-2770.
PubMed

DIEDRICH L
Illness politics and social media mobilisation.
Lancet. 2024;403:2776-2777.
PubMed

THE LANCET
UK elections: the need for a healthy change.
Lancet. 2024;403:2755.
PubMed

GARCIA PJ, Saavedra J, Espinoza-Pajuelo L, Garcia-Terron FA, et al
Why Latin America needs a regional Centre for Disease Control and Prevention.
Lancet. 2024;403:2763-2765.
PubMed

SCHRECKER T
Canada's reckoning?
Lancet. 2024;403:2688.
PubMed

ZAROCOSTAS J
Mental health in emergencies requires "a major rethink".
Lancet. 2024;403:2582.
PubMed

AHSAN S
Israel border closure denying health care to Gazans.
Lancet. 2024;403:2581.
PubMed

SAMARASEKERA U
African vaccine manufacturing scheme to boost production.
Lancet. 2024;403:2579-2580.
PubMed

KUNKLER I
Improving future UK pandemic management structure.
Lancet. 2024;403:2592.
PubMed

YOON JH, Kwon IH, Park HW
The South Korean health-care system in crisis.
Lancet. 2024;403:2589.
PubMed

THE LANCET
Taking persistent physical symptoms seriously.
Lancet. 2024;403:2565.
PubMed

MCCALL C
Security concerns threaten Papua New Guinea relief efforts.
Lancet. 2024;403:2471.
PubMed

KOMAMURA K, Iwase M
Clinical outcomes of the AdaptResponse trial.
Lancet. 2024;403:2484.
PubMed

FILIPPATOS G, Gold MR, Mullens W, Kusano K, et al
Clinical outcomes of the AdaptResponse trial - Authors' reply.
Lancet. 2024;403:2484-2485.
PubMed

HORTON R
Offline: The system is not working.
Lancet. 2024;403:2470.
PubMed

THE LANCET
H5N1: international failures and uncomfortable truths.
Lancet. 2024;403:2455.
PubMed

MOHAPATRA PR
Responding to India's data and transparency.
Lancet. 2024;403:2482-2483.
PubMed

ANIRVAN P
Blowing in the wind-India's health data and transparency issues.
Lancet. 2024;403:2483-2484.
PubMed

WATTS G
Martin Raw.
Lancet. 2024;403:2372.
PubMed

SAMARASEKERA U
Calls for a focus on health risks in EU election.
Lancet. 2024;403:2364.
PubMed

TORNINI VA, Fernandez RW, Goldman OV, Suarez J, et al
DEI infrastructures required for the best science and medicine.
Lancet. 2024;403:2375.
PubMed

HORTON R
Offline: UK election-two issues you won't hear about.
Lancet. 2024;403:2362.
PubMed

May 2024

PATERLINI M
Warnings over Italian health-care devolution.
Lancet. 2024;403:2279.
PubMed

THORNTON J
Infected blood report release marks a day of shame for the UK.
Lancet. 2024;403:2276-2277.
PubMed

BROWN M, Gerrard J, McDougall C, MacPhail J, et al
Purpura fulminans in young women with influenza and co-infections.
Lancet. 2024;403:2290-2291.
PubMed

THE LANCET
Cyberattacks on health care-a growing threat.
Lancet. 2024;403:2263.
PubMed

LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878.
PubMed Abstract available

SAMARASEKERA U
50 years of the Expanded Programme on Immunization.
Lancet. 2024;403:1971-1972.
PubMed

MARCATO AJ, Meagher N, Spirkoska V, Arnott A, et al
One Health pandemic preparedness: the role of companion animals in disease transmission.
Lancet. 2024;403:1984-1985.
PubMed

ADAMU AA, Ndwandwe D, Jalo RI, Muhammad ID, et al
Cofinancing immunisation through national health insurance.
Lancet. 2024;403:1983-1984.
PubMed

HORTON R
Offline: Indifference-the biggest threat to global health.
Lancet. 2024;403:1970.
PubMed

KANTER R, Fort MP
Rethinking health policy: life expectancy and mortality in an era of polycrisis.
Lancet. 2024;403:1956-1958.
PubMed

WATTS G
Alasdair Macintosh Geddes.
Lancet. 2024;403:1846.
PubMed

AUJLA M
Art, plunder, fragile fault lines.
Lancet. 2024;403:1844-1845.
PubMed

USHER AD
Organisations vie for control over pandemic financing.
Lancet. 2024;403:1839-1840.
PubMed

GREENHALGH T, MacIntyre CR, Ungrin M, Wright JM, et al
Airborne pathogens: controlling words won't control transmission.
Lancet. 2024;403:1850-1851.
PubMed

YANG YT
Protecting humanitarian aid workers: an urgent call.
Lancet. 2024;403:1847.
PubMed

ABUZERR S, Zinser K
Amplifying the voices of women in the Gaza Strip.
Lancet. 2024;403:1848-1849.
PubMed

KOJIMA N, Adlhoch C, Mitja O, Dat VQ, et al
Building global preparedness for avian influenza.
Lancet. 2024 May 9:S0140-6736(24)00934-6. doi: 10.1016/S0140-6736(24)00934.
PubMed

KNUPPEL A, Boyd A, Macleod J, Chaturvedi N, et al
The long COVID evidence gap in England.
Lancet. 2024 May 6:S0140-6736(24)00744-X. doi: 10.1016/S0140-6736(24)00744.
PubMed

KIVIMAKI M, Batty GD
Work as a health risk.
Lancet. 2024;403:1747-1748.
PubMed

April 2024

GREEN A
Tobias Welte.
Lancet. 2024;403:1626.
PubMed

MARCHALIK D, Rehm D
On not cutting corners.
Lancet. 2024;403:1623.
PubMed

DEVI S
Swedish NGOs are reeling after government cuts.
Lancet. 2024;403:1527.
PubMed

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
PubMed Abstract available

ZUMLA A, Peiris M, Memish ZA, Perlman S, et al
Anticipating a MERS-like coronavirus as a potential pandemic threat.
Lancet. 2024 Apr 8:S0140-6736(24)00641-X. doi: 10.1016/S0140-6736(24)00641.
PubMed

PETO L, Basnyat B, Horby P
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
Lancet. 2024;403:1339-1340.
PubMed

BHUSAL S, Adhikari S
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1339.
PubMed

NARASARAJU T, Ravi Y, Jonsson CB, Chow VTK, et al
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1338-1339.
PubMed

HSU NC, Tokuda Y
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1338.
PubMed

MCEVOY N, Lowry J, O'Dowd A, Curley GF, et al
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1337.
PubMed

HASHIM Z, Nath A, Tripathy NK
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1337-1338.
PubMed

SORAAS A, Brunvoll SH, Nygaard AB, Dahl JA, et al
Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan.
Lancet. 2024;403:1336.
PubMed

GU X, Huang L, Zhang H, Cao B, et al
Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan - Authors' reply.
Lancet. 2024;403:1336-1337.
PubMed

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
PubMed Abstract available

March 2024

SZANYI J, Howe S, Blakely T
The importance of reporting accurate estimates of long COVID prevalence.
Lancet. 2024;403:1136-1137.
PubMed

WENHAM C, Stout L
A legal mapping of 48 WHO member states' inclusion of public health emergency of international concern, pandemic, and health emergency terminology within national emergency legislation in responding to health emergencies.
Lancet. 2024 Mar 22:S0140-6736(24)00156-9. doi: 10.1016/S0140-6736(24)00156.
PubMed Abstract available

SHAWE-TAYLOR M, Greenwood D, Hobbs A, Dowgier G, et al
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
Lancet. 2024 Mar 11:S0140-6736(24)00316-7. doi: 10.1016/S0140-6736(24)00316.
PubMed

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
PubMed Abstract available

PARHIZ H, Atochina-Vasserman EN, Weissman D
mRNA-based therapeutics: looking beyond COVID-19 vaccines.
Lancet. 2024 Mar 7:S0140-6736(23)02444-3. doi: 10.1016/S0140-6736(23)02444.
PubMed Abstract available

February 2024

ROSAS-SALAZAR C, Gebretsadik T, Dupont WD, Hartert TV, et al
The INSPIRE study: RSV infection during infancy - Authors' reply.
Lancet. 2024;403:729-730.
PubMed

HSU NC, Hsu CH
The INSPIRE study: RSV infection during infancy.
Lancet. 2024;403:729.
PubMed

TAO L, Liu J
The INSPIRE study: RSV infection during infancy.
Lancet. 2024;403:728-729.
PubMed

DHAIRYAWAN R
Candour, care, and COVID-19.
Lancet. 2024;403:718.
PubMed

VORA NM, Hassan L, Plowright RK, Horton R, et al
The Lancet-PPATS Commission on Prevention of Viral Spillover: reducing the risk of pandemics through primary prevention.
Lancet. 2024;403:597-599.
PubMed

WANG X, Li Y, Shi T, Bont LJ, et al
Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
Lancet. 2024 Feb 14:S0140-6736(24)00138-7. doi: 10.1016/S0140-6736(24)00138.
PubMed Abstract available

ADERINTO N, Olatunji G, Kokori E
Health implications of GSK's departure from Nigeria.
Lancet. 2024;403:526-527.
PubMed

January 2024

MCCLOSKEY B, Saito T, Shimada S, Ikenoue C, et al
The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt.
Lancet. 2024 Jan 17:S0140-6736(23)02635-1. doi: 10.1016/S0140-6736(23)02635.
PubMed Abstract available

WANG L, Wang Q, Gao GF
Interpreting COVID-19 data from China: a call for caution - Authors' reply.
Lancet. 2024;403:144-145.
PubMed

QU Z
Interpreting COVID-19 data from China: a call for caution.
Lancet. 2024;403:144.
PubMed

GULLIFORD MC, Steves CJ
Access to COVID-19 vaccination and COVID-19-related hospital admissions and mortality.
Lancet. 2024 Jan 12:S0140-6736(23)02622-3. doi: 10.1016/S0140-6736(23)02622.
PubMed

Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales.
Lancet. 2024 Jan 12:S0140-6736(23)02467-4. doi: 10.1016/S0140-6736(23)02467.
PubMed Abstract available

SHAH SA, Robertson C, Sheikh A
Effects of the COVID-19 pandemic on NHS England waiting times for elective hospital care: a modelling study.
Lancet. 2024 Jan 11:S0140-6736(23)02744-7. doi: 10.1016/S0140-6736(23)02744.
PubMed

December 2023

GILES-VERNICK T, Cheah PY, Matta G, Lima NT, et al
Louis Pasteur, COVID-19, and the social challenges of epidemics.
Lancet. 2023;400:2166-2168.
PubMed

CHARLIER P
Death and end of life in France after COVID-19.
Lancet. 2023;402:2290.
PubMed

HORTON R
Offline: Boris Johnson and COVID-19-more light than heat.
Lancet. 2023;402:2277.
PubMed

November 2023

GRABAR-KITAROVIC K, Phumaphi J
A crisis of trust in pandemic prevention, preparedness, and response.
Lancet. 2023;402:1730-1732.
PubMed

ZIAUDDEEN N, Pantelic M, O'Hara ME, Hastie C, et al
Impact of long COVID-19 on work: a co-produced survey.
Lancet. 2023;402 Suppl 1:S98.
PubMed Abstract available

VAN YPEREN J, Campillo-Funollet E, Memon A, Allman P, et al
The Sussex COVID-19 Modelling Cell: the methods and successes of a collaboration between public health teams in local authorities, NHS hospital trusts, NHS commissioners, and universities.
Lancet. 2023;402 Suppl 1:S94.
PubMed Abstract available

Nowcasting waiting lists for elective procedures and surgery in England: a modelling study.
Lancet. 2023;402 Suppl 1:S74.
PubMed Abstract available

MORENO-AGOSTINO D, Das-Munshi J, Ploubidis GB
Differences in the impact of the COVID-19 pandemic in the long-term trajectories of life satisfaction by sex in the UK: a prospective cohort study.
Lancet. 2023;402 Suppl 1:S71.
PubMed Abstract available

MARTIN A, Jamieson S
Exploring the experiences of junior doctors who were shielding during the COVID-19 pandemic: a qualitative study of semi-structured interviews.
Lancet. 2023;402 Suppl 1:S68.
PubMed Abstract available

KROMYDAS T, Demou E, Leyland AH, Katikireddi SV, et al
Effect of trade unions on the mental health of UK workers before and during the COVID-19 pandemic: a longitudinal analysis using Understanding Society data.
Lancet. 2023;402 Suppl 1:S62.
PubMed Abstract available

KHAN Y, Verhaeghe N, Devleesschauwer B, Cavillot L, et al
Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review.
Lancet. 2023;402 Suppl 1:S61.
PubMed Abstract available

KALBUS A, Cornelsen L, Ballatore A, Cummins S, et al
Changes in food and drink purchasing behaviour in England during the first 3 months of the COVID-19 pandemic: an interrupted time-series analysis.
Lancet. 2023;402 Suppl 1:S60.
PubMed Abstract available

HAZIR SG, Ryan C, Moore A, Lewis C, et al
The role of the multiple Index of deprivation in predicting mental health outcomes after the COVID-19 pandemic in adolescents: a cross-sectional study.
Lancet. 2023;402 Suppl 1:S47.
PubMed Abstract available

DU Z, Wang L, Bai Y, Pei Y, et al
Mitigation of respiratory syncytial virus epidemics by RSVpreF vaccines after the COVID-19 pandemic in the UK: a modelling study.
Lancet. 2023;402 Suppl 1:S39.
PubMed Abstract available

ARNOTT J, Troya MI, Joyce M, Khashan A, et al
Untangling the association between COVID-19 health literacy, trust in the pandemic response, and mental distress, during the COVID-19 pandemic in Ireland: a repeated cross-sectional study.
Lancet. 2023;402 Suppl 1:S23.
PubMed Abstract available

October 2023

WANG Q, Bowen A, Ho J, Zhang RM, et al
SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster.
Lancet. 2023 Oct 31:S0140-6736(23)02278-X. doi: 10.1016/S0140-6736(23)02278.
PubMed

DELFRAISSY JF, Horgan M, Molbak K, Simon FS, et al
Scientific advisory councils in the COVID-19 response.
Lancet. 2023 Oct 12:S0140-6736(23)01846-9. doi: 10.1016/S0140-6736(23)01846.
PubMed

September 2023

MATUCHANSKY C
Natural SARS-CoV-2 infection-induced immune protection against re-infection.
Lancet. 2023;402:1131.
PubMed

FLACCO ME, Martellucci CA, Manzoli L
Extra data to confirm waning protection of omicron (B.1.1.529) natural immunity.
Lancet. 2023;402:1129.
PubMed

YANG C, Lapp L, Tebbutt SJ
Overcoming COVID-19 vaccine hesitancy hurdles.
Lancet. 2023;402:1129-1130.
PubMed

TSAGKARIS C, Papazoglou AS, Moysidis DV, Papadakos SP, et al
Striving to afford free health care in Greece during COVID-19.
Lancet. 2023;402:1128-1129.
PubMed

JASSAT W, Reyes LF, Munblit D, Caoili J, et al
Long COVID in low-income and middle-income countries: the hidden public health crisis.
Lancet. 2023;402:1115-1117.
PubMed

HOCHMAYR C, Kiechl-Kohlendorfer U, Griesmaier E
COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection - Authors' reply.
Lancet. 2023;402:1132.
PubMed

QU Z
Cautionary notes on the COVID-19 re-infection study.
Lancet. 2023;402:1130-1131.
PubMed

ZHOU YB, Xu ZG
COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection.
Lancet. 2023;402:1131-1132.
PubMed

PALUMBO L, Picchio CA, Smallwood C, Salvi C, et al
Community COVID-19 response in WHO's European region.
Lancet. 2023;402:1127.
PubMed

MASSUDA A, Dall'Alba R, Chioro A, Temporao JG, et al
Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges - Authors' reply.
Lancet. 2023;402:1041-1042.
PubMed

PARENTE RCM, Queiroga M
Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges.
Lancet. 2023;402:1040-1041.
PubMed

ZHANG H
COVID-19 and Chinese nurses' mental health.
Lancet. 2023;402:1039-1040.
PubMed

August 2023

DAI L, Duan H, Liu X, Zhou H, et al
Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection.
Lancet. 2023;402:687-689.
PubMed

KUNG S, Hills T, Kearns N, Beasley R, et al
New Zealand's COVID-19 elimination strategy and mortality patterns.
Lancet. 2023 Aug 24:S0140-6736(23)01368-5. doi: 10.1016/S0140-6736(23)01368.
PubMed

IFTEKHAR N, Sivan M
Venous insufficiency and acrocyanosis in long COVID: dysautonomia.
Lancet. 2023;402:e9.
PubMed

KNAUL FM, Arreola-Ornelas H, Touchton M, McDonald T, et al
Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption.
Lancet. 2023 Aug 7:S0140-6736(23)00777-8. doi: 10.1016/S0140-6736(23)00777.
PubMed Abstract available

July 2023

HSU NC, Hsu CH
COVID-19 and commerce complicate minimum unit pricing effects on health.
Lancet. 2023;402:368.
PubMed

WYPER GM, Mackay DF, Fraser C, Lewsey J, et al
COVID-19 and commerce complicate minimum unit pricing effects on health - Authors' reply.
Lancet. 2023;402:368-369.
PubMed

O'BRIEN KL, Lemango E
The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery.
Lancet. 2023 Jul 17:S0140-6736(23)01468-X. doi: 10.1016/S0140-6736(23)01468.
PubMed

June 2023

WIJAYA R, Johnson M, Campbell N, Stuart B, et al
Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing.
Lancet. 2023 Jun 29:S0140-6736(23)01180-7. doi: 10.1016/S0140-6736(23)01180.
PubMed

The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860.
PubMed Abstract available

PELOSI A
Disrespectful language about patients with long COVID.
Lancet. 2023;401:2108.
PubMed

PRIYA GIRI S, Dubey A
Loneliness in the time of COVID-19: an alarming rise.
Lancet. 2023;401:2107-2108.
PubMed

BAILEY C, Sanderson T, Townsley H, Goldman J, et al
Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London.
Lancet. 2023 Jun 19:S0140-6736(23)00917-0. doi: 10.1016/S0140-6736(23)00917.
PubMed

LEGIDO-QUIGLEY H, Clark H, Nishtar S, Horton R, et al
Reimagining health security and preventing future pandemics: the NUS-Lancet Pandemic Readiness, Implementation, Monitoring, and Evaluation Commission.
Lancet. 2023;401:2021-2023.
PubMed

HUANG C, Huang L, Wang Y, Li X, et al
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
Lancet. 2023 Jun 12:S0140-6736(23)00810-3. doi: 10.1016/S0140-6736(23)00810.
PubMed Abstract available

PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874.
PubMed Abstract available

LAL A, Schwalbe N
Primary health care: a cornerstone of pandemic prevention, preparedness, response, and recovery.
Lancet. 2023;401:1847.
PubMed

May 2023

JAFFE S
US health experts divided on social media age restrictions.
Lancet. 2023;401:1757.
PubMed

Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response.
Lancet. 2023 May 26:S0140-6736(23)00964-9. doi: 10.1016/S0140-6736(23)00964.
PubMed

FLAHAULT A, Calmy A, Costagliola D, Drapkina O, et al
No time for complacency on COVID-19 in Europe.
Lancet. 2023 May 22:S0140-6736(23)01012-7. doi: 10.1016/S0140-6736(23)01012.
PubMed

ZAROCOSTAS J
With the COVID-19 PHEIC over, what next?
Lancet. 2023;401:1642-1643.
PubMed

MFINANGA SG, Gatei W, Tinuga F, Mwengee WMP, et al
Tanzania's COVID-19 vaccination strategy: lessons, learning, and execution.
Lancet. 2023;401:1649.
PubMed

JAFFE S
US Surgeon General: loneliness is a public health crisis.
Lancet. 2023;401:1560.
PubMed

EMANUEL EJ, Persad G
The shared ethical framework to allocate scarce medical resources: a lesson from COVID-19.
Lancet. 2023 May 9:S0140-6736(23)00812-7. doi: 10.1016/S0140-6736(23)00812.
PubMed Abstract available

April 2023

AGRAWAL U, Robertson C, Sheikh A
Moving towards a precision approach for prevention of severe COVID-19 - Authors' reply.
Lancet. 2023;401:1424.
PubMed

BRANCH-ELLIMAN W, Monach PA
Moving towards a precision approach for prevention of severe COVID-19.
Lancet. 2023;401:1423-1424.
PubMed

SZAPOCZNIK J, Faviero G, Dansua AS, Bausch DG, et al
The importance of accountability in tackling future pandemics.
Lancet. 2023;401:1423.
PubMed

GALVAO J
COVID-19: forgetting a pandemic that is not over.
Lancet. 2023;401:1422-1423.
PubMed

THE LANCET
Moving past the COVID-19 emergency in the USA.
Lancet. 2023;401:1399.
PubMed

ROSS I, Bick S, Ayieko P, Dreibelbis R, et al
Effectiveness of handwashing with soap for preventing acute respiratory infections in low-income and middle-income countries: a systematic review and meta-analysis.
Lancet. 2023 Apr 27:S0140-6736(23)00021-1. doi: 10.1016/S0140-6736(23)00021.
PubMed Abstract available

CUENI T
Lessons learned from COVID-19 to stop future pandemics.
Lancet. 2023;401:1340.
PubMed

HORTON R
Offline: The UK COVID-19 Inquiry-be patient, but don't wait.
Lancet. 2023;401:1324.
PubMed

LURIE N, Sharfstein JM
State-to-state differences in US COVID-19 outcomes: searching for explanations.
Lancet. 2023;401:1314-1315.
PubMed

BILLARD MN, Bont LJ
The link between respiratory syncytial virus infection during infancy and asthma during childhood.
Lancet. 2023 Apr 19:S0140-6736(23)00672-4. doi: 10.1016/S0140-6736(23)00672.
PubMed

ROSAS-SALAZAR C, Chirkova T, Gebretsadik T, Chappell JD, et al
Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study.
Lancet. 2023 Apr 19:S0140-6736(23)00811-5. doi: 10.1016/S0140-6736(23)00811.
PubMed Abstract available

PETROV AN, Dorough DS, Tiwari S, Welford M, et al
Indigenous health-care sovereignty defines resilience to the COVID-19 pandemic.
Lancet. 2023 Apr 18:S0140-6736(23)00684-0. doi: 10.1016/S0140-6736(23)00684.
PubMed

HOCHMAYR C, Auckenthaler M, Fink FM, Kiechl-Kohlendorfer U, et al
Differential diagnosis of blue toes in a newborn baby: might have been maternal infection with COVID-19?
Lancet. 2023;401:e20.
PubMed

GOH AXC, Chae SR, Chiew CJ, Tang N, et al
Characteristics of the omicron XBB subvariant wave in Singapore.
Lancet. 2023;401:1261-1262.
PubMed

KING B, Zhang X, Harcha WG, Szepietowski JC, et al
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
Lancet. 2023 Apr 13:S0140-6736(23)00222-2. doi: 10.1016/S0140-6736(23)00222.
PubMed Abstract available

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Lancet. 2023 Apr 12:S0140-6736(23)00510-X. doi: 10.1016/S0140-6736(23)00510.
PubMed Abstract available

PERNER A, Venkatesh B
Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?
Lancet. 2023 Apr 12:S0140-6736(23)00587-1. doi: 10.1016/S0140-6736(23)00587.
PubMed

March 2023

SUN L, Jia H, Yang T
Chinese medical personnel after the COVID-19 pandemic.
Lancet. 2023;401:1000.
PubMed

BOLLYKY TJ, Castro E, Aravkin AY, Bhangdia K, et al
Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
Lancet. 2023 Mar 22:S0140-6736(23)00461-0. doi: 10.1016/S0140-6736(23)00461.
PubMed Abstract available

QU Z
International cooperation to end the COVID-19 pandemic.
Lancet. 2023;401:820.
PubMed

THE LANCET
Long COVID: 3 years in.
Lancet. 2023;401:795.
PubMed

Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
Lancet. 2023;401:833-842.
PubMed Abstract available

COHEN C, Pulliam J
COVID-19 infection, reinfection, and the transition to endemicity.
Lancet. 2023;401:798-800.
PubMed

STOCKWELL M
Effect of a nationwide intervention of electronic letters with behavioural nudges on influenza vaccination in older adults in Denmark.
Lancet. 2023 Mar 3:S0140-6736(23)00453-1. doi: 10.1016/S0140-6736(23)00453.
PubMed

JOHANSEN ND, Vaduganathan M, Bhatt AS, Lee SG, et al
Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trial.
Lancet. 2023 Mar 3:S0140-6736(23)00349-5. doi: 10.1016/S0140-6736(23)00349.
PubMed Abstract available

CARPIANO RM, Callaghan T, DiResta R, Brewer NT, et al
Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era.
Lancet. 2023 Mar 2:S0140-6736(23)00136-8. doi: 10.1016/S0140-6736(23)00136.
PubMed

February 2023

HUANG S, Gao Z, Wang S
China's COVID-19 reopening measures-warriors and weapons.
Lancet. 2023;401:643-644.
PubMed

HAY SI, Murray CJL
Conflicting COVID-19 excess mortality estimates - Authors' reply.
Lancet. 2023;401:433-434.
PubMed

BAGER P, Nielsen J, Bhatt S, Nielsen LB, et al
Conflicting COVID-19 excess mortality estimates.
Lancet. 2023;401:432-433.
PubMed

DONZELLI A
Conflicting COVID-19 excess mortality estimates.
Lancet. 2023;401:432.
PubMed

MOETI M, Makubalo L, Gueye AS, Balde T, et al
Conflicting COVID-19 excess mortality estimates.
Lancet. 2023;401:431.
PubMed

O'NEILL D
Conflicting COVID-19 excess mortality estimates.
Lancet. 2023;401:431.
PubMed

SCHOLEY J, Karlinsky A, Kobak D, Tallack C, et al
Conflicting COVID-19 excess mortality estimates.
Lancet. 2023;401:431-432.
PubMed

PAN Y, Wang L, Feng Z, Xu H, et al
Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis.
Lancet. 2023 Feb 8:S0140-6736(23)00129-0. doi: 10.1016/S0140-6736(23)00129.
PubMed Abstract available

PREISER W, Maponga T
So far, no novel SARS-CoV-2 variants from Beijing-and hopefully better scientific cooperation going forward.
Lancet. 2023 Feb 8:S0140-6736(23)00268-4. doi: 10.1016/S0140-6736(23)00268.
PubMed

TAN H, Liu J, Zeng F
China needs a scientific long COVID recovery-support platform.
Lancet. 2023;401:344-345.
PubMed

January 2023

MOHEBBI N, Ritter A, Wiegand A, Graf N, et al
Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
Lancet. 2023 Jan 25:S0140-6736(22)02606-X. doi: 10.1016/S0140-6736(22)02606.
PubMed Abstract available

ELNAIEM A, Mohamed-Ahmed O, Zumla A, Mecaskey J, et al
Global and regional governance of One Health and implications for global health security.
Lancet. 2023 Jan 19:S0140-6736(22)01597-5. doi: 10.1016/S0140-6736(22)01597.
PubMed Abstract available

TRAORE T, Shanks S, Haider N, Ahmed K, et al
How prepared is the world? Identifying weaknesses in existing assessment frameworks for global health security through a One Health approach.
Lancet. 2023 Jan 19:S0140-6736(22)01589-6. doi: 10.1016/S0140-6736(22)01589.
PubMed Abstract available

MWATONDO A, Rahman-Shepherd A, Hollmann L, Chiossi S, et al
A global analysis of One Health Networks and the proliferation of One Health collaborations.
Lancet. 2023 Jan 19:S0140-6736(22)01596-3. doi: 10.1016/S0140-6736(22)01596.
PubMed Abstract available

ELLINGTON S, Jatlaoui TC
COVID-19 vaccination is effective at preventing severe illness and complications during pregnancy.
Lancet. 2023 Jan 17:S0140-6736(22)02613-7. doi: 10.1016/S0140-6736(22)02613.
PubMed

VILLAR J, Soto Conti CP, Gunier RB, Ariff S, et al
Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.
Lancet. 2023 Jan 17:S0140-6736(22)02467-9. doi: 10.1016/S0140-6736(22)02467.
PubMed Abstract available

THE LANCET
The COVID-19 pandemic in 2023: far from over.
Lancet. 2023;401:79.
PubMed

BAKER MG, Durrheim D, Hsu LY, Wilson N, et al
COVID-19 and other pandemics require a coherent response strategy.
Lancet. 2023 Jan 13:S0140-6736(22)02489-8. doi: 10.1016/S0140-6736(22)02489.
PubMed

December 2022

TIBBLE H, Mueller T, Proud E, Hall E, et al
Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland.
Lancet. 2022 Dec 22:S0140-6736(22)02398-4. doi: 10.1016/S0140-6736(22)02398.
PubMed

KIDD MR, Kelly PM
PANORAMIC: important insights into molnupiravir use in COVID-19.
Lancet. 2022 Dec 22:S0140-6736(22)02593-4. doi: 10.1016/S0140-6736(22)02593.
PubMed

BUTLER CC, Hobbs FDR, Gbinigie OA, Rahman NM, et al
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
Lancet. 2022 Dec 22:S0140-6736(22)02597-1. doi: 10.1016/S0140-6736(22)02597.
PubMed Abstract available

SELVARAJAH S, Corona Maioli S, Deivanayagam TA, de Morais Sato P, et al
Racism, xenophobia, and discrimination: mapping pathways to health outcomes.
Lancet. 2022;400:2109-2124.
PubMed Abstract available

DEVAKUMAR D, Selvarajah S, Abubakar I, Kim SS, et al
Racism, xenophobia, discrimination, and the determination of health.
Lancet. 2022;400:2097-2108.
PubMed Abstract available

ELSON W, Zambon M, de Lusignan S
Integrated respiratory surveillance after the COVID-19 pandemic.
Lancet. 2022;400:1924-1925.
PubMed

November 2022

JAFFE S
US CDC begins agency-wide changes after pandemic failures.
Lancet. 2022;400:1754-1755.
PubMed

HORTON R
Offline: COVID-19-the lessons that science forgot.
Lancet. 2022;400:1753.
PubMed

GOSTIN LO, Friedman EA, Hossain S, Mukherjee J, et al
Human rights and the COVID-19 pandemic: a retrospective and prospective analysis.
Lancet. 2022 Nov 17:S0140-6736(22)01278-8. doi: 10.1016/S0140-6736(22)01278.
PubMed Abstract available

OWEN A, Diaz JV, Guyatt G, Lamontagne F, et al
WHO Living Guidelines on antivirals for COVID-19 are evidence-based.
Lancet. 2022 Nov 10. pii: S0140-6736(22)02306.
PubMed

KALRA PR, Cleland JGF, Petrie MC, Thomson EA, et al
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
Lancet. 2022 Nov 4. pii: S0140-6736(22)02083.
PubMed Abstract available

October 2022

Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries.
Lancet. 2022 Oct 31. pii: S0140-6736(22)01846.
PubMed Abstract available

FRENK J, Chen LC, Chandran L, Groff EOH, et al
Challenges and opportunities for educating health professionals after the COVID-19 pandemic.
Lancet. 2022;400:1539-1556.
PubMed Abstract available

AGUS DB, Nguyen A, Sall AA, Bell J, et al
COVID-19 and other adult vaccines can drive global disease prevention.
Lancet. 2022 Oct 27. pii: S0140-6736(22)02084.
PubMed

OPEL DJ, Brewer NT, Buttenheim AM, Callaghan T, et al
The legacy of the COVID-19 pandemic for childhood vaccination in the USA.
Lancet. 2022 Oct 26. pii: S0140-6736(22)01693.
PubMed

LEFRANCOIS T, Malvy D, Atlani-Duault L, Benamouzig D, et al
After 2 years of the COVID-19 pandemic, translating One Health into action is urgent.
Lancet. 2022 Oct 21. pii: S0140-6736(22)01840.
PubMed

AGRAWAL U, Bedston S, McCowan C, Oke J, et al
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
Lancet. 2022;400:1305-1320.
PubMed Abstract available

MSELLATI P, Sow K, Desclaux A, Cottrell G, et al
Reconsidering the COVID-19 vaccine strategy in West and Central Africa.
Lancet. 2022;400:1304.
PubMed

IRVING SA, Sundaram ME
Prioritisation of COVID-19 boosters in the omicron era.
Lancet. 2022;400:1282-1283.
PubMed

WONG CKH, Au ICH, Lau KTK, Lau EHY, et al
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kon
Lancet. 2022;400:1213-1222.
PubMed Abstract available

BURDET C, Ader F
Real-world effectiveness of oral antivirals for COVID-19.
Lancet. 2022;400:1175-1176.
PubMed

FRENK J, Godal T, Gomez-Dantes O, Store JG, et al
A reinvigorated multilateralism in health: lessons and innovations from the COVID-19 pandemic.
Lancet. 2022 Oct 7. pii: S0140-6736(22)01943.
PubMed

WU MY, Carr EJ, Harvey R, Mears HV, et al
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.
Lancet. 2022 Oct 6. pii: S0140-6736(22)01938.
PubMed

September 2022

HAMEED SS, Hall E, Grange Z, Sullivan C, et al
Characterising adults in Scotland who are not vaccinated against COVID-19.
Lancet. 2022;400:993-995.
PubMed

ZIEGLER T, Moen A, Zhang W, Cox NJ, et al
Global Influenza Surveillance and Response System: 70 years of responding to the expected and preparing for the unexpected.
Lancet. 2022;400:981-982.
PubMed

THE LANCET
COVID-19: the case for prosociality.
Lancet. 2022 Sep 14. pii: S0140-6736(22)01761.
PubMed

SACHS JD, Karim SSA, Aknin L, Allen J, et al
The Lancet Commission on lessons for the future from the COVID-19 pandemic.
Lancet. 2022 Sep 14. pii: S0140-6736(22)01585.
PubMed

YEK C, Warner S, Mancera A, Kadri SS, et al
Misclassification bias in estimating clinical severity of SARS-CoV-2 variants.
Lancet. 2022;400:809.
PubMed

NYBERG T, Ferguson NM, Blake J, Hinsley W, et al
Misclassification bias in estimating clinical severity of SARS-CoV-2 variants - Authors' reply.
Lancet. 2022;400:809-810.
PubMed

ZHANG Y, Wang Y, Ning G, He P, et al
Protecting older people: a high priority during the COVID-19 pandemic.
Lancet. 2022;400:729-730.
PubMed

THORNTON J
New centre for pandemic therapeutics.
Lancet. 2022;400:722.
PubMed

August 2022

UYEKI TM, Hui DS, Zambon M, Wentworth DE, et al
Influenza.
Lancet. 2022;400:693-706.
PubMed Abstract available

BOLLYKY TJ, Angelino O, Wigley S, Dieleman JL, et al
Trust made the difference for democracies in COVID-19.
Lancet. 2022;400:657.
PubMed

PICKERSGILL M, Manda-Taylor L, Nino-Machado N
Pandemic preparedness means policy makers need to work with social scientists.
Lancet. 2022;400:547-549.
PubMed

BALLERING AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, et al
Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.
Lancet. 2022;400:452-461.
PubMed Abstract available

SORENSEN RJD
COVID-19 and microbiome diversity in sub-Saharan Africa - Author's reply.
Lancet. 2022;400:429-430.
PubMed

VAN DAMME W, Wamai R, Assefa Y, Liesenborghs L, et al
COVID-19 and microbiome diversity in sub-Saharan Africa.
Lancet. 2022;400:429.
PubMed

BRIGHTLING CE, Evans RA
Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
Lancet. 2022;400:411-413.
PubMed

July 2022

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Lancet. 2022;400:359-368.
PubMed Abstract available

THORNTON J
Violence against health workers rises during COVID-19.
Lancet. 2022;400:348.
PubMed

MEHTA P, Titanji BK
Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality.
Lancet. 2022;400:338-339.
PubMed

DALZIEL SR, Haskell L, O'Brien S, Borland ML, et al
Bronchiolitis.
Lancet. 2022;400:392-406.
PubMed Abstract available

LAWTON T, Alwan NA
The UK COVID-19 Inquiry must examine the foundations of pandemic decision making.
Lancet. 2022 Jul 18. pii: S0140-6736(22)01332.
PubMed

MESSACAR K, Baker RE, Park SW, Nguyen-Tran H, et al
Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption.
Lancet. 2022 Jul 14. pii: S0140-6736(22)01277.
PubMed

DURRHEIM DN
Perilous two-tier COVID-19 global vaccine roll-out.
Lancet. 2022 Jul 11. pii: S0140-6736(22)01284.
PubMed

WOLTER N, Jassat W, von Gottberg A, Cohen C, et al
Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa.
Lancet. 2022;400:93-96.
PubMed

MELLO MM, Opel DJ, Benjamin RM, Callaghan T, et al
Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA.
Lancet. 2022 Jul 8. pii: S0140-6736(22)00875.
PubMed

GOGA A, Bekker LG, Garrett N, Reddy T, et al
Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.
PubMed

NASSIRI-ANSARI T, Atuhebwe P, Ayisi AS, Goulding S, et al
Shifting gender barriers in immunisation in the COVID-19 pandemic response and beyond.
Lancet. 2022;400:24.
PubMed

PFAFF F, Hoffmann D, Beer M
Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2.
Lancet. 2022;400:22-23.
PubMed

June 2022

SACCO C, Del Manso M, Mateo-Urdiales A, Rota MC, et al
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
Lancet. 2022 Jun 30. pii: S0140-6736(22)01185.
PubMed Abstract available

LADHANI SN
COVID-19 vaccination for children aged 5-11 years.
Lancet. 2022 Jun 30. pii: S0140-6736(22)01245.
PubMed

BURKI T
COVID-19 in North Korea.
Lancet. 2022;399:2339.
PubMed

ANTONELLI M, Pujol JC, Spector TD, Ourselin S, et al
Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2.
Lancet. 2022;399:2263-2264.
PubMed

OFRI D
Memorialising COVID-19.
Lancet. 2022;399:2260-2261.
PubMed

LI G, Cappuccini F, Marchevsky NG, Aley PK, et al
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
Lancet. 2022;399:2212-2225.
PubMed Abstract available

WONG HL, Hu M, Zhou CK, Lloyd PC, et al
Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
Lancet. 2022;399:2191-2199.
PubMed Abstract available

PATEL M, Patel M
Increasing children's global access to COVID-19 vaccines.
Lancet. 2022;399:2171-2173.
PubMed

HUSBY A, Kober L
COVID-19 mRNA vaccination and myocarditis or pericarditis.
Lancet. 2022;399:2168-2169.
PubMed

May 2022

HARTERT TV, Ortiz JR
Need for improved global measurement of early childhood respiratory syncytial virus disease.
Lancet. 2022;399:1993-1995.
PubMed

LI Y, Wang X, Blau DM, Caballero MT, et al
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.
Lancet. 2022;399:2047-2064.
PubMed Abstract available

CLARK H, Cardenas M, Dybul M, Kazatchkine M, et al
Transforming or tinkering: the world remains unprepared for the next pandemic threat.
Lancet. 2022;399:1995-1999.
PubMed

NELLUMS LB, Latif A, Nkhoma K, Timmons S, et al
COVID-19 boosters and building trust among UK minority ethnic communities.
Lancet. 2022 May 25. pii: S0140-6736(22)00945.
PubMed

DENNEHY JJ, Gupta RK, Hanage WP, Johnson MC, et al
Where is the next SARS-CoV-2 variant of concern?
Lancet. 2022;399:1938-1939.
PubMed

HORTON R
Offline: How to fix pandemic preparedness.
Lancet. 2022;399:1927.
PubMed

KICKBUSCH I, Liu A
Global health diplomacy-reconstructing power and governance.
Lancet. 2022 May 17. pii: S0140-6736(22)00583.
PubMed Abstract available

YUAN S
Zero COVID in China: what next?
Lancet. 2022;399:1856-1857.
PubMed

SHERLOCK PL
COVID-19 and inter-generational solidarity.
Lancet. 2022;399:1775.
PubMed

THE LANCET
COVID-19: the next phase and beyond.
Lancet. 2022;399:1753.
PubMed

BHUTTA ZA, Boerma T, Black MM, Victora CG, et al
Optimising child and adolescent health and development in the post-pandemic world.
Lancet. 2022;399:1759-1761.
PubMed

JHA P, Brown PE, Ansumana R
Counting the global COVID-19 dead.
Lancet. 2022 May 6. pii: S0140-6736(22)00845.
PubMed

ZHANG X, Zhang W, Chen S
Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic.
Lancet. 2022 May 6. pii: S0140-6736(22)00838.
PubMed

CHRISTENSON SA, Smith BM, Bafadhel M, Putcha N, et al
Chronic obstructive pulmonary disease.
Lancet. 2022 May 6. pii: S0140-6736(22)00470.
PubMed Abstract available

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
Lancet. 2022 May 2. pii: S0140-6736(22)00519.
PubMed Abstract available

April 2022

ADEPOJU P
Africa CDC warns COVID-19 vaccine production could cease.
Lancet. 2022;399:1683.
PubMed

VICTORA CG, Hartwig FP, Vidaletti LP, Martorell R, et al
Effects of early-life poverty on health and human capital in children and adolescents: analyses of national surveys and birth cohort studies in LMICs.
Lancet. 2022;399:1741-1752.
PubMed Abstract available

ARCHARD D, Buyx A, Delfraissy JF
Responding to the humanitarian crisis of the war in Ukraine with lessons from COVID-19.
Lancet. 2022 Apr 25. pii: S0140-6736(22)00731.
PubMed

GRAMMATOPOULOS DK, Young L, Anderson NR
Transforming the UK's diagnostics agenda after COVID-19.
Lancet. 2022;399:1606.
PubMed

JEFFORD M, Howell D, Li Q, Lisy K, et al
Improved models of care for cancer survivors.
Lancet. 2022;399:1551-1560.
PubMed Abstract available

NTOUMI F, Zumla A
Advancing accurate metrics for future pandemic preparedness.
Lancet. 2022;399:1443-1445.
PubMed

FISHER D, Suri S, Carson G
What comes next in the COVID-19 pandemic?
Lancet. 2022 Apr 11. pii: S0140-6736(22)00580.
PubMed

BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
Lancet. 2022;399:e36.
PubMed

LOGUNOV DY, Livermore DM, Ornelles DA, Bayer W, et al
COVID-19 vaccination and HIV-1 acquisition.
Lancet. 2022;399:e34-e35.
PubMed

DWEK RA, Bell JI, Feldmann M, Zitzmann N, et al
Host-targeting oral antiviral drugs to prevent pandemics.
Lancet. 2022;399:1381-1382.
PubMed

Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
Lancet. 2022 Apr 8. pii: S0140-6736(22)00484.
PubMed Abstract available

SHIODA K, Lopman B
How to interpret the total number of SARS-CoV-2 infections.
Lancet. 2022 Apr 8. pii: S0140-6736(22)00629.
PubMed

MENNI C, Valdes AM, Polidori L, Antonelli M, et al
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
Lancet. 2022 Apr 7. pii: S0140-6736(22)00327.
PubMed Abstract available

HAN X, Li J, Chen Y, Li Y, et al
SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment.
Lancet. 2022 Apr 7. pii: S0140-6736(22)00577.
PubMed

BERGMARK BA, Mathenge N, Merlini PA, Lawrence-Wright MB, et al
Acute coronary syndromes.
Lancet. 2022;399:1347-1358.
PubMed Abstract available

KHOBRAGADE A, Bhate S, Ramaiah V, Deshpande S, et al
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India.
Lancet. 2022;399:1313-1321.
PubMed Abstract available

ZAROCOSTAS J
Mixed response to COVID-19 intellectual property waiver.
Lancet. 2022;399:1292-1293.
PubMed

BLAKNEY AK, Bekker LG
DNA vaccines join the fight against COVID-19.
Lancet. 2022;399:1281-1282.
PubMed

POST LA, Lorenzo-Redondo R
Omicron: fewer adverse outcomes come with new dangers.
Lancet. 2022;399:1280-1281.
PubMed

March 2022

LUKE JJ, Rutkowski P, Queirolo P, Del Vecchio M, et al
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
Lancet. 2022 Mar 31. pii: S0140-6736(22)00562.
PubMed Abstract available

KRAUSE PR, Rees H, Figueroa JP, Swaminathan S, et al
Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply.
Lancet. 2022;399:1225.
PubMed

NIXON DF, Schwartz RE, Ndhlovu LC
Booster vaccines for COVID-19 vaccine breakthrough cases?
Lancet. 2022;399:1224.
PubMed

NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.
Lancet. 2022;399:1266-1278.
PubMed Abstract available

SWETS MC, Russell CD, Harrison EM, Docherty AB, et al
SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.
Lancet. 2022 Mar 25. pii: S0140-6736(22)00383.
PubMed

KOLA L, Kumar M, Kohrt BA, Fatodun T, et al
Strengthening public mental health during and after the acute phase of the COVID-19 pandemic.
Lancet. 2022 Mar 24. pii: S0140-6736(22)00523.
PubMed

WATERS L, Marra F, Pozniak A, Cockburn J, et al
Ritonavir and COVID-19: pragmatic guidance is important.
Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.
PubMed

BEKKER LG, Garrett N, Goga A, Fairall L, et al
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
Lancet. 2022;399:1141-1153.
PubMed Abstract available

NYBERG T, Ferguson NM, Nash SG, Webster HH, et al
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
Lancet. 2022 Mar 16. pii: S0140-6736(22)00462.
PubMed Abstract available

MILLS EJ, Reis G
Evaluating COVID-19 vaccines in the real world.
Lancet. 2022 Mar 15. pii: S0140-6736(22)00194.
PubMed

REARTE A, Castelli JM, Rearte R, Fuentes N, et al
Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study.
Lancet. 2022 Mar 15. pii: S0140-6736(22)00011.
PubMed Abstract available

HAAGMANS BL, Koopmans MPG
Spreading of SARS-CoV-2 from hamsters to humans.
Lancet. 2022;399:1027-1028.
PubMed

YEN HL, Sit THC, Brackman CJ, Chuk SSY, et al
Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study.
Lancet. 2022;399:1070-1078.
PubMed Abstract available

KHAN W, Abubakar A, Brennan RJ, Al Hosani F, et al
Preparing for future pandemics in the Eastern Mediterranean region.
Lancet. 2022;399:1032-1033.
PubMed

Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
Lancet. 2022 Mar 10. pii: S0140-6736(21)02796.
PubMed Abstract available

FALLAH MP, Reinhart E
Apartheid logic in global health.
Lancet. 2022;399:902-903.
PubMed

CORREIA LCL, Sette C, Santos M, Magliano CAS, et al
Brazil's COVID-19 guidelines: political hijack of public health.
Lancet. 2022 Mar 3. pii: S0140-6736(22)00338.
PubMed

KUCHARSKI AJ, Jit M, Logan JG, Cotten M, et al
Travel measures in the SARS-CoV-2 variant era need clear objectives.
Lancet. 2022 Mar 2. pii: S0140-6736(22)00366.
PubMed

FLOR LS, Friedman J, Spencer CN, Cagney J, et al
Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021.
Lancet. 2022 Mar 2. pii: S0140-6736(22)00008.
PubMed Abstract available

MORGAN R, Pimenta DN, Rashid S
Gender equality and COVID-19: act now before it is too late.
Lancet. 2022 Mar 2. pii: S0140-6736(22)00278.
PubMed

February 2022

CHEMAITELLY H, Abu-Raddad LJ
Waning effectiveness of COVID-19 vaccines.
Lancet. 2022;399:771-773.
PubMed

USHER AD
The global COVID-19 treatment divide.
Lancet. 2022;399:779-782.
PubMed

THE LANCET
Our commitment to help accelerate progress against cancer.
Lancet. 2022;399:769.
PubMed

Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
Lancet. 2022 Feb 24. pii: S0140-6736(21)02867.
PubMed Abstract available

GU X, Cao B
Understanding of COVID-19 from infection-fatality ratio.
Lancet. 2022 Feb 24. pii: S0140-6736(22)00281.
PubMed

PIECHOTTA V, Harder T
Waning of COVID-19 vaccine effectiveness: individual and public health risk.
Lancet. 2022 Feb 21. pii: S0140-6736(22)00282.
PubMed

FEIKIN DR, Higdon MM, Abu-Raddad LJ, Andrews N, et al
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
Lancet. 2022 Feb 21. pii: S0140-6736(22)00152.
PubMed Abstract available

KALAFAT E, Magee LA, von Dadelszen P, Heath P, et al
COVID-19 booster doses in pregnancy and global vaccine equity.
Lancet. 2022 Feb 18. pii: S0140-6736(22)00166.
PubMed

MADHI SA, Ihekweazu C, Rees H, Pollard AJ, et al
Decoupling of omicron variant infections and severe COVID-19.
Lancet. 2022 Feb 18. pii: S0140-6736(22)00109.
PubMed

DINEEN K, Autzen B, Alwan NA
Children, intersectionality, and COVID-19.
Lancet. 2022 Feb 16. pii: S0140-6736(22)00174.
PubMed

SARDINHA L, Maheu-Giroux M, Stockl H, Meyer SR, et al
Global, regional, and national prevalence estimates of physical or sexual, or both, intimate partner violence against women in 2018.
Lancet. 2022 Feb 16. pii: S0140-6736(21)02664.
PubMed Abstract available

EGGER S, Egger G
The vaccinated propor-tion of people with COVID-19 needs context.
Lancet. 2022;399:627.
PubMed

MUSSINI C, Cozzi-Lepri A
Another piece in the COVID-19 treatment puzzle.
Lancet. 2022;399:609-610.
PubMed

ADAMS LV, Dorough DS
Accelerating Indigenous health and wellbeing: the Lancet Commission on Arctic and Northern Health.
Lancet. 2022;399:613-614.
PubMed

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Lancet. 2022;399:665-676.
PubMed Abstract available

LOPEZ A, Srigley J
Transmission of SARS-CoV-2: still up in the air.
Lancet. 2022;399:519.
PubMed

GREENHALGH T, Jimenez JL, Prather KA, Tufeki Z, et al
Transmission of SARS-CoV-2: still up in the air - Authors' reply.
Lancet. 2022;399:519-520.
PubMed

DALY M, Robinson E
Depression and anxiety during COVID-19.
Lancet. 2022;399:518.
PubMed

SANTOMAURO DF, Whiteford HA, Ferrari AJ
Depression and anxiety during COVID-19 - Authors' reply.
Lancet. 2022;399:518-519.
PubMed

SAMARASEKERA U
Ayoade Alakija: advancing equity in the COVID-19 response.
Lancet. 2022;399:511.
PubMed

ZAROCOSTAS J
WHO concerned over COVID-19 health-care waste.
Lancet. 2022;399:507.
PubMed

BURKI T
Fresh questions over Gates Foundation governance.
Lancet. 2022;399:508.
PubMed

HUMPHREYS K, Shover CL, Andrews CM, Bohnert ASB, et al
Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
Lancet. 2022;399:555-604.
PubMed

THE LANCET
Managing the opioid crisis in North America and beyond.
Lancet. 2022;399:495.
PubMed

BEYRER C
Archbishop Desmond Tutu and the universality of health and human rights.
Lancet. 2022;399:503-504.
PubMed

NORDSTROM P, Ballin M, Nordstrom A
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden.
Lancet. 2022 Feb 4. pii: S0140-6736(22)00089.
PubMed Abstract available

KARAFILLAKIS E, Van Damme P, Hendrickx G, Larson HJ, et al
COVID-19 in Europe: new challenges for addressing vaccine hesitancy.
Lancet. 2022 Feb 3. pii: S0140-6736(22)00150.
PubMed

Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
Lancet. 2022 Feb 1. pii: S0140-6736(22)00172.
PubMed Abstract available

January 2022

HOLT E
Polish Government COVID-19 advisors resign.
Lancet. 2022;399:424.
PubMed

NEALON J, Cowling BJ
Omicron severity: milder but not mild.
Lancet. 2022;399:412-413.
PubMed

ADAMS R
Urgent care: disability, pandemic, and the value of a life.
Lancet. 2022;399:430-431.
PubMed

JAFFE S
The next steps for US vaccine mandates.
Lancet. 2022;399:425-426.
PubMed

SO-OSMAN C, Valk SJ
High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19.
Lancet. 2022 Jan 27. pii: S0140-6736(22)00112.
PubMed

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial.
Lancet. 2022 Jan 27. pii: S0140-6736(22)00101.
PubMed Abstract available

HUBSCHEN JM, Gouandjika-Vasilache I, Dina J
Measles.
Lancet. 2022 Jan 27. pii: S0140-6736(21)02004.
PubMed Abstract available

FENDLER A, Shepherd STC, Au L, Wu M, et al
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
Lancet. 2022 Jan 25. pii: S0140-6736(22)00147.
PubMed

TANG TB
The COVID-19 response in Hong Kong.
Lancet. 2022;399:357.
PubMed

ALFIERI C, Egrot M, Desclaux A, Sams K, et al
Recognising Italy's mistakes in the public health response to COVID-19.
Lancet. 2022;399:357-358.
PubMed

QURESHI I, Gogoi M, Al-Oraibi A, Wobi F, et al
Intersectionality and developing evidence-based policy.
Lancet. 2022;399:355-356.
PubMed

BROWN K, Yahyouche A, Haroon S, Camaradou J, et al
Long COVID and self-management.
Lancet. 2022;399:355.
PubMed

LANE R
Jamal Rifi: family doctor building bridges in the community.
Lancet. 2022;399:353.
PubMed

COSTA CLEMENS SA, Weckx L, Clemens R, Almeida Mendes AV, et al
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
Lancet. 2022 Jan 21. pii: S0140-6736(22)00094.
PubMed Abstract available

BRAVO L, Smolenov I, Han HH, Li P, et al
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
Lancet. 2022 Jan 20. pii: S0140-6736(22)00055.
PubMed Abstract available

VESIKARI T
Trimeric S protein COVID-19 vaccine needs to find its place.
Lancet. 2022 Jan 20. pii: S0140-6736(22)00096.
PubMed

CARR EJ, Wu M, Harvey R, Billany RE, et al
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients.
Lancet. 2022 Jan 20. pii: S0140-6736(22)00104.
PubMed

WOLTER N, Jassat W, Walaza S, Welch R, et al
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
Lancet. 2022 Jan 19. pii: S0140-6736(22)00017.
PubMed Abstract available

MURRAY CJL
COVID-19 will continue but the end of the pandemic is near.
Lancet. 2022 Jan 19. pii: S0140-6736(22)00100.
PubMed

WU M, Wall EC, Carr EJ, Harvey R, et al
Three-dose vaccination elicits neutralising antibodies against omicron.
Lancet. 2022 Jan 19. pii: S0140-6736(22)00092.
PubMed

KUHLMANN C, Mayer CK, Claassen M, Maponga T, et al
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.
Lancet. 2022 Jan 18. pii: S0140-6736(22)00090.
PubMed

LAXMINARAYAN R
The overlooked pandemic of antimicrobial resistance.
Lancet. 2022 Jan 18. pii: S0140-6736(22)00087.
PubMed

VALAIYAPATHI R, Wu MS, McGregor A
Ground glass opacities are not always COVID-19: a case of acute eosinophilic pneumonitis caused by daptomycin.
Lancet. 2022;399:270.
PubMed

PUNTIS JWL
The UK People's Covid Inquiry.
Lancet. 2022;399:236.
PubMed

MCCALL C
Disrupted care in Papua New Guinea: the harms of COVID-19.
Lancet. 2022;399:226-227.
PubMed

HARMAN S
The wall.
Lancet. 2022;399:136-137.
PubMed

BARBARO RP, MacLaren G, Swol J, Slutsky AS, et al
COVID-19 ARDS: getting ventilation right - Authors' reply.
Lancet. 2022;399:22-23.
PubMed

PEREZ-FERNANDEZ XL, Sabater-Riera J, Fuset-Cabanes M
COVID-19 ARDS: getting ventilation right.
Lancet. 2022;399:22.
PubMed

HESKIN J, Pallett SJC, Mughal N, Davies GW, et al
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management.
Lancet. 2022;399:21-22.
PubMed

THE LANCET
The state of science and society in 2022.
Lancet. 2022;399:1.
PubMed

December 2021

KING J, Ferraz OLM, Jones A
Mandatory COVID-19 vaccination and human rights.
Lancet. 2021 Dec 23. pii: S0140-6736(21)02873.
PubMed

HALPERIN SA, Ye L, MacKinnon-Cameron D, Smith B, et al
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-
Lancet. 2021 Dec 23. pii: S0140-6736(21)02753.
PubMed Abstract available

KENNEDY RB
Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine.
Lancet. 2021 Dec 23. pii: S0140-6736(21)02834.
PubMed

ORMISTON CK, Williams F
LGBTQ youth mental health during COVID-19: unmet needs in public health and policy.
Lancet. 2021 Dec 22. pii: S0140-6736(21)02872.
PubMed

LEUNG K, Wu JT
Managing waning vaccine protection against SARS-CoV-2 variants.
Lancet. 2021 Dec 20. pii: S0140-6736(21)02841.
PubMed

KATIKIREDDI SV, Cerqueira-Silva T, Vasileiou E, Robertson C, et al
Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
Lancet. 2021 Dec 20. pii: S0140-6736(21)02754.
PubMed Abstract available

DEJNIRATTISAI W, Shaw RH, Supasa P, Liu C, et al
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
Lancet. 2021 Dec 20. pii: S0140-6736(21)02844.
PubMed

PEELING RW, Heymann DL, Teo YY, Garcia PJ, et al
Diagnostics for COVID-19: moving from pandemic response to control.
Lancet. 2021 Dec 20. pii: S0140-6736(21)02346.
PubMed Abstract available

THE LANCET
Science during COVID-19: where do we go from here?
Lancet. 2021;396:1941.
PubMed

FLEISHMAN R
Dreams deferred.
Lancet. 2021;396:2083-2084.
PubMed

DANIELS JP
Caribbean rainy season batters health care.
Lancet. 2021;396:1955.
PubMed

HALL V, Hopkins S
COV-BOOST: evidence to support rapid booster deployment.
Lancet. 2021;398:2209-2211.
PubMed

THE LANCET
COVID-19: where do we go from here?
Lancet. 2021;398:2207.
PubMed

MOLLICA RF, Fricchione GL
Mental and physical exhaustion of health-care practitioners.
Lancet. 2021;398:2243-2244.
PubMed

ZAROCOSTAS J
WHO and World Bank urge spending for UHC.
Lancet. 2021;398:2223.
PubMed

DEVI S
Russia-Ukraine tensions hampering health-care access.
Lancet. 2021;398:2222.
PubMed

COVIDSURG COLLABORATIVE
Projecting COVID-19 disruption to elective surgery.
Lancet. 2021 Dec 16. pii: S0140-6736(21)02836.
PubMed

MCINTYRE PB, Aggarwal R, Jani I, Jawad J, et al
COVID-19 vaccine strategies must focus on severe disease and global equity.
Lancet. 2021 Dec 16. pii: S0140-6736(21)02835.
PubMed

BRADBURY CA, McQuilten Z
Anticoagulation in COVID-19.
Lancet. 2021 Dec 15. pii: S0140-6736(21)02503.
PubMed

RAMACCIOTTI E, Barile Agati L, Calderaro D, Aguiar VCR, et al
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial.
Lancet. 2021 Dec 15. pii: S0140-6736(21)02392.
PubMed Abstract available

LIPWORTH B, Chan R, Misirovs R
High-dose budesonide for early COVID-19.
Lancet. 2021;398:2147.
PubMed

HOBBS FDR, Yu LM, Saville BR, Bafadhel M, et al
High-dose budesonide for early COVID-19 - Authors' reply.
Lancet. 2021;398:2147-2148.
PubMed

BEREZOWSKI I, Patel J, Shaw M, Pourmand A, et al
High-dose budesonide for early COVID-19.
Lancet. 2021;398:2146-2147.
PubMed

THE LANCET
Preventing violence against women: beyond 16 days.
Lancet. 2021;398:2125.
PubMed

MOON S, Armstrong J, Hutler B, Upshur R, et al
Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability.
Lancet. 2021 Dec 10. pii: S0140-6736(21)02344.
PubMed Abstract available

RICHARDSON CD
Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19.
Lancet. 2021 Dec 6. pii: S0140-6736(21)02757.
PubMed

STUART ASV, Shaw RH, Liu X, Greenland M, et al
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Lancet. 2021 Dec 6. pii: S0140-6736(21)02718.
PubMed Abstract available

DEVI S
Health warnings over UNRWA funding shortfall.
Lancet. 2021;398:2063.
PubMed

ZAROCOSTAS J
Hope for nutrition summit as global hunger spikes.
Lancet. 2021;398:2061-2062.
PubMed

WARD H, Flower B, Garcia PJ, Ong SWX, et al
Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.
Lancet. 2021;398:2057-2059.
PubMed

KARIM SSA, Karim QA
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.
Lancet. 2021 Dec 3. pii: S0140-6736(21)02758.
PubMed

MENDELSON M, Venter F, Moshabela M, Gray G, et al
The political theatre of the UK's travel ban on South Africa.
Lancet. 2021 Dec 3. pii: S0140-6736(21)02752.
PubMed

MUNRO APS, Janani L, Cornelius V, Aley PK, et al
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
Lancet. 2021 Dec 2. pii: S0140-6736(21)02717.
PubMed Abstract available

November 2021

SIMBAYI LC, Moyo S, van Heerden A, Zuma K, et al
Global HIV efforts need to focus on key populations in LMICs.
Lancet. 2021 Nov 29. pii: S0140-6736(21)02692.
PubMed

KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
COVID-19 and myocardial infarction - Authors' reply.
Lancet. 2021;398:1964.
PubMed

SAWADOGO NH, Sanou H, Greene JA, Duclos V, et al
Beyond COVID-19: scaling up and sustaining mobile health in Africa - Authors' reply.
Lancet. 2021;398:1963.
PubMed

CALDEIRA D, Pinto FJ
COVID-19 and myocardial infarction.
Lancet. 2021;398:1963-1964.
PubMed

BOUM Y
Beyond COVID-19: scaling up and sustaining mobile health in Africa.
Lancet. 2021;398:1962-1963.
PubMed

JOLLY J
A reproductive justice response to HIV/AIDS and COVID-19.
Lancet. 2021;398:1958-1959.
PubMed

SMITH K, Brooks W, Challiner J, Povey E, et al
Quality assurance of remote clinical assessments in the NHS.
Lancet. 2021;398:1962.
PubMed

LANE R
Pascale Ondoa: strengthening laboratory medicine in Africa.
Lancet. 2021;398:1955.
PubMed

FLEMING KA, Horton S, Wilson ML, Atun R, et al
The Lancet Commission on diagnostics: transforming access to diagnostics.
Lancet. 2021;398:1997-2050.
PubMed

YANG C, Zhao H, Tebbutt SJ
Long-term effects on survivors with COVID-19.
Lancet. 2021;398:1872.
PubMed

HUANG L, Gu X, Cao B
Long-term effects on survivors with COVID-19 - Authors' reply.
Lancet. 2021;398:1872-1873.
PubMed

KAMPF G
COVID-19: stigmatising the unvaccinated is not justified.
Lancet. 2021;398:1871.
PubMed

ZHAO YJ, Bai W, Su Z, Ng CH, et al
Long-term effects on survivors with COVID-19.
Lancet. 2021;398:1871-1872.
PubMed

JAFFE S
Legal challenges threaten Biden's COVID-19 vaccine rule.
Lancet. 2021;398:1863-1864.
PubMed

KNEEBONE R, Houstoun W, Houghton N
Medicine, magic, and online performance.
Lancet. 2021;398:1868-1869.
PubMed

BURKI T
mRNA discoveries earn the 2021 Prince Mahidol Award.
Lancet. 2021;398:1865.
PubMed

SPYROPOULOS AC, Bonaca MP
Studying the coagulopathy of COVID-19.
Lancet. 2021 Nov 17. pii: S0140-6736(21)01906.
PubMed

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Lancet. 2021 Nov 17. pii: S0140-6736(21)01825.
PubMed Abstract available

OMER SB, Benjamin RM, Brewer NT, Buttenheim AM, et al
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.
Lancet. 2021 Nov 15. pii: S0140-6736(21)02507.
PubMed Abstract available

LAZARUS R, Baos S, Cappel-Porter H, Carson-Stevens A, et al
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
Lancet. 2021 Nov 11. pii: S0140-6736(21)02329.
PubMed Abstract available

LI JX, Zhu FC
Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19.
Lancet. 2021 Nov 11. pii: S0140-6736(21)02014.
PubMed

ELLA R, Reddy S, Blackwelder W, Potdar V, et al
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
Lancet. 2021 Nov 11. pii: S0140-6736(21)02000.
PubMed Abstract available

SINGH S, McNab C, Olson RM, Bristol N, et al
How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic.
Lancet. 2021 Nov 8. pii: S0140-6736(21)01897.
PubMed Abstract available

ALVES L
Health experts welcome Brazil COVID-19 inquiry findings.
Lancet. 2021;398:1674-1675.
PubMed

KICKBUSCH I, Piselli D, Agrawal A, Balicer R, et al
The Lancet and Financial Times Commission on governing health futures 2030: growing up in a digital world.
Lancet. 2021;398:1727-1776.
PubMed

MCMULLEN AM
The choice to love.
Lancet. 2021;398:1680-1681.
PubMed

USHER AD
New budget and strategy for ACT-A.
Lancet. 2021;398:1677.
PubMed

ZAROCOSTAS J
WHO's Tedros set to be re-elected unopposed.
Lancet. 2021;398:1676.
PubMed

THE LANCET
Can digital technologies improve health?
Lancet. 2021;398:1663.
PubMed

ORTIZ JR, Neuzil KM
The value of vaccine programme impact monitoring during the COVID-19 pandemic.
Lancet. 2021 Nov 3. pii: S0140-6736(21)02322.
PubMed

MCNAMARA LA, Wiegand RE, Burke RM, Sharma AJ, et al
Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data.
Lancet. 2021 Nov 3. pii: S0140-6736(21)02226.
PubMed Abstract available

October 2021

GOLD C
Unclear conclusions on SARS-CoV-2 elimination versus mitigation.
Lancet. 2021;398:1566.
PubMed

OLIU-BARTON M, Pradelski BSR, Aghion P, Artus P, et al
Unclear conclusions on SARS-CoV-2 elimination versus mitigation - Authors' reply.
Lancet. 2021;398:1566-1567.
PubMed

DANIELS JP
Nicaraguan health-care workers under attack.
Lancet. 2021;398:1555-1556.
PubMed

BAR-YAM Y, Gurdasani D, Baker MG, Scally G, et al
The World Health Network: a global citizens' initiative.
Lancet. 2021;398:1567-1568.
PubMed

BARDA N, Dagan N, Cohen C, Hernan MA, et al
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.
Lancet. 2021 Oct 29. pii: S0140-6736(21)02249.
PubMed Abstract available

GRANGE Z, Buelo A, Sullivan C, Moore E, et al
Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland.
Lancet. 2021 Oct 28. pii: S0140-6736(21)02316.
PubMed

LEUNG GM
Nowcasting towards sustainable SARS-CoV-2 endemicity.
Lancet. 2021 Oct 27. pii: S0140-6736(21)02386.
PubMed

SONABEND R, Whittles LK, Imai N, Perez-Guzman PN, et al
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
Lancet. 2021 Oct 27. pii: S0140-6736(21)02276.
PubMed Abstract available

XUE W, White A
COVID-19 and the rebiologisation of racial difference.
Lancet. 2021;398:1479-1480.
PubMed

MAKONI M
African Medicines Agency to be established.
Lancet. 2021;398:1475.
PubMed

USHER AD
Vaccine shortages prompt changes to COVAX strategy.
Lancet. 2021;398:1474.
PubMed

The Lancet Commission on water, sanitation and hygiene, and health.
Lancet. 2021;398:1469-1470.
PubMed

RICCIARDI W, Tarricone R
The evolution of the Italian National Health Service.
Lancet. 2021 Oct 22. pii: S0140-6736(21)01733.
PubMed Abstract available

HILLSON K, Clemens SC, Madhi SA, Voysey M, et al
Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination.
Lancet. 2021 Oct 21. pii: S0140-6736(21)02282.
PubMed

SAAG MS
Developing COVID-19 vaccine policy in increments.
Lancet. 2021;398:1382-1383.
PubMed

LOPES RD, de Barros E Silva PGM, Furtado RHM, Alexander JH, et al
Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply.
Lancet. 2021;398:1304.
PubMed

ZUIN M, Rigatelli G, Zuliani G, Roncon L, et al
Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19.
Lancet. 2021;398:1303-1304.
PubMed

MYERS SS, Pivor JI, Saraiva AM
The Sao Paulo Declaration on Planetary Health.
Lancet. 2021;398:1299.
PubMed

TAQUET M, Holmes EA, Harrison PJ
Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns.
Lancet. 2021 Oct 8. pii: S0140-6736(21)02221.
PubMed

Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.
Lancet. 2021 Oct 8. pii: S0140-6736(21)02143.
PubMed Abstract available

KOLA L, Kohrt BA, Acharya B, Mutamba BB, et al
The path to global equity in mental health care in the context of COVID-19.
Lancet. 2021 Oct 7. pii: S0140-6736(21)02233.
PubMed

KLEINERT S, Horton R
Can COVID-19 help accelerate and transform the diagnostics agenda?
Lancet. 2021 Oct 5. pii: S0140-6736(21)02093.
PubMed

PRENDECKI M, Thomson T, Clarke CL, Martin P, et al
Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients.
Lancet. 2021 Oct 4. pii: S0140-6736(21)02096.
PubMed

TARTOF SY, Slezak JM, Fischer H, Hong V, et al
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.
Lancet. 2021 Oct 4. pii: S0140-6736(21)02183.
PubMed Abstract available

DE FOO C, Grepin KA, Cook AR, Hsu LY, et al
Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore.
Lancet. 2021 Oct 4. pii: S0140-6736(21)02186.
PubMed

TORRES I, Profeta B, Machado CV, Artaza O, et al
COVID-19 research in LMICs - Authors' reply.
Lancet. 2021;398:1213.
PubMed

SISA I, Fornasini M, Teran E
COVID-19 research in LMICs.
Lancet. 2021;398:1212-1213.
PubMed

VUYLSTEKE A
ECMO in COVID-19: do not blame the tool.
Lancet. 2021;398:1197-1199.
PubMed

BARBARO RP, MacLaren G, Boonstra PS, Combes A, et al
Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry.
Lancet. 2021;398:1230-1238.
PubMed Abstract available

VINER RM, Koirala A
Daily antigen testing to reduce disruption when schools return.
Lancet. 2021;398:1196-1197.
PubMed

September 2021

PINTO FJ, Pineiro D, Banerjee A, Perel P, et al
World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease.
Lancet. 2021 Sep 28. pii: S0140-6736(21)02144.
PubMed

THE LANCET
COVID-19: learning as an interdependent world.
Lancet. 2021;398:1105.
PubMed

AAVITSLAND P, Aguilera X, Al-Abri SS, Amani V, et al
Functioning of the International Health Regulations during the COVID-19 pandemic.
Lancet. 2021 Sep 24. pii: S0140-6736(21)01911.
PubMed

OGBUOJI O, Mao W, Aryeetey G
The long-term impact of COVID-19 on development assistance for health is still uncertain.
Lancet. 2021 Sep 22. pii: S0140-6736(21)01448.
PubMed

Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.
Lancet. 2021 Sep 22. pii: S0140-6736(21)01258.
PubMed Abstract available

WU Z, Jin Q, Wu G, Lu J, et al
SARS-CoV-2's origin should be investigated worldwide for pandemic prevention.
Lancet. 2021 Sep 17. pii: S0140-6736(21)02020.
PubMed

VAN HELDEN J, Butler CD, Achaz G, Canard B, et al
An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2.
Lancet. 2021 Sep 17. pii: S0140-6736(21)02019.
PubMed

KEUSCH GT, Lam SK, Mackenzie JS, Saif L, et al
An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 - Authors' reply.
Lancet. 2021 Sep 17. pii: S0140-6736(21)02013.
PubMed

SHARFSTEIN JM, Callaghan T, Carpiano RM, Sgaier SK, et al
Uncoupling vaccination from politics: a call to action.
Lancet. 2021 Sep 16. pii: S0140-6736(21)02099.
PubMed

YOUNG BC, Eyre DW, Kendrick S, White C, et al
Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial.
Lancet. 2021 Sep 14. pii: S0140-6736(21)01908.
PubMed Abstract available

KRAUSE PR, Fleming TR, Peto R, Longini IM, et al
Considerations in boosting COVID-19 vaccine immune responses.
Lancet. 2021 Sep 14. pii: S0140-6736(21)02046.
PubMed

LANE R
Gagandeep Kang: helping to shape a healthier India.
Lancet. 2021;398:947.
PubMed

DANIELS JP
Earthquake compounds Haiti's health challenges.
Lancet. 2021;398:944-945.
PubMed

MONTI M, Torbica A, Mossialos E, McKee M, et al
A new strategy for health and sustainable development in the light of the COVID-19 pandemic.
Lancet. 2021 Sep 9. pii: S0140-6736(21)01995.
PubMed

HARVEY SB, Epstein RM, Glozier N, Petrie K, et al
Mental illness and suicide among physicians.
Lancet. 2021;398:920-930.
PubMed Abstract available

BOSELEY S
The race to make a COVID-19 vaccine.
Lancet. 2021;398:832-833.
PubMed

JERVING S
The long road ahead for COVID-19 vaccination in Africa.
Lancet. 2021;398:827-828.
PubMed

GAMALLIEL N, Saminarsih D, Taher A
Indonesia's second wave crisis: medical doctors' political role is needed more than ever.
Lancet. 2021;398:839-840.
PubMed

ROGAWSKI MCQUADE ET, Breskin A
Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine.
Lancet. 2021 Sep 1. pii: S0140-6736(21)01817.
PubMed

KASEJE N, Walcott D
Global youth advocating for COVID-19 vaccines for all.
Lancet. 2021 Sep 1. pii: S0140-6736(21)01994.
PubMed

August 2021

THE LANCET
Understanding long COVID: a modern medical challenge.
Lancet. 2021;398:725.
PubMed

LANGLOIS EV, Dey T, Shah MG
More than honour, humanitarian health-care workers need life-saving protection.
Lancet. 2021;398:729-730.
PubMed

ZUNIGA JM, Russell A, Lusimbo R, Tshabalala S, et al
The costs of PEPFAR's leadership vacuum.
Lancet. 2021;398:741.
PubMed

HUANG L, Yao Q, Gu X, Wang Q, et al
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
Lancet. 2021;398:747-758.
PubMed Abstract available

LINDENFELD J, Zile MR, Desai AS, Bhatt K, et al
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
Lancet. 2021 Aug 26. pii: S0140-6736(21)01754.
PubMed Abstract available

SOAR J, Becker LB, Berg KM, Einav S, et al
Cardiopulmonary resuscitation in special circumstances.
Lancet. 2021 Aug 26. pii: S0140-6736(21)01257.
PubMed Abstract available

SALLES A, Jagsi R
Institutional imperatives for the advancement of women in medicine and science through the COVID-19 pandemic.
Lancet. 2021 Aug 24. pii: S0140-6736(21)01912.
PubMed

JUNI P, da Costa BR, Bobos P, Bodmer NS, et al
Revisiting the evidence for physical distancing, face masks, and eye protection.
Lancet. 2021;398:663.
PubMed

CHU D, Khamis A, Akl E, Neumann I, et al
Revisiting the evidence for physical distancing, face masks, and eye protection - Authors' reply.
Lancet. 2021;398:663-664.
PubMed

ZHOU Q, Wang X, Estill J, Yang K, et al
Revisiting the evidence for physical distancing, face masks, and eye protection.
Lancet. 2021;398:661.
PubMed

ABBAS M, Goto M, Tartari E, Perencevich E, et al
Revisiting the evidence for physical distancing, face masks, and eye protection.
Lancet. 2021;398:661-663.
PubMed

SCORRANO L, Baglivo I, Cavallo DM, Cecconi F, et al
Revisiting the evidence for physical distancing, face masks, and eye protection.
Lancet. 2021;398:660-661.
PubMed

LIJFERING WM
Revisiting the evidence for physical distancing, face masks, and eye protection.
Lancet. 2021;398:659-660.
PubMed

COGHLAN R
Broaden the narrative this World Humanitarian Day: honour those who comfort the dying.
Lancet. 2021;398:659.
PubMed

ROCHON PA, Kalia S, Higgs P
Gendered ageism: addressing discrimination based on age and sex.
Lancet. 2021;398:648-649.
PubMed

ADEPOJU P
West Africa on alert for haemorrhagic fevers.
Lancet. 2021;398:653.
PubMed

USHER AD
Health leaders criticise limited ACT-A review.
Lancet. 2021;398:650-651.
PubMed

BEHRENS GM, Cossmann A, Stankov MV, Nehlmeier I, et al
SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination.
Lancet. 2021 Aug 17. pii: S0140-6736(21)01891.
PubMed

Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019.
Lancet. 2021 Aug 17. pii: S0140-6736(21)01207.
PubMed Abstract available

THORNTON J
Focusing on island health.
Lancet. 2021;398:569-570.
PubMed

DANIELS JP
Haiti's health woes intensify.
Lancet. 2021;398:567.
PubMed

FRIEDEN TR, Lee CT, Bochner AF, Buissonniere M, et al
7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics.
Lancet. 2021;398:638-640.
PubMed

BEHAGUE D, Ortega F
Mutual aid, pandemic politics, and global social medicine in Brazil.
Lancet. 2021;398:575-576.
PubMed

ETIENNE CF
Tackling Latin America's COVID-19 emergency requires greater solidarity.
Lancet. 2021 Aug 12. pii: S0140-6736(21)01757.
PubMed

READ JM, Green CA, Harrison EM, Docherty AB, et al
Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave.
Lancet. 2021 Aug 12. pii: S0140-6736(21)01786.
PubMed

CARR EJ, Wu M, Harvey R, Wall EC, et al
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.
Lancet. 2021 Aug 12. pii: S0140-6736(21)01854.
PubMed

KALAFAT E, Magee LA, von Dadelszen P, O'Brien P, et al
SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity.
Lancet. 2021 Aug 11. pii: S0140-6736(21)01756.
PubMed

MANGIN D, Howard M
The use of inhaled corticosteroids in early-stage COVID-19.
Lancet. 2021 Aug 10. pii: S0140-6736(21)01809.
PubMed

PUNG R, Mak TM, Kucharski AJ, Lee VJ, et al
Serial intervals in SARS-CoV-2 B.1.617.2 variant cases.
Lancet. 2021 Aug 10. pii: S0140-6736(21)01697.
PubMed

YU LM, Bafadhel M, Dorward J, Hayward G, et al
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
Lancet. 2021 Aug 10. pii: S0140-6736(21)01744.
PubMed Abstract available

PRIESEMANN V, Balling R, Bauer S, Beutels P, et al
Towards a European strategy to address the COVID-19 pandemic.
Lancet. 2021 Aug 9. pii: S0140-6736(21)01808.
PubMed

BICCARD BM, Thomson D, Miller M, Taylor EH, et al
Critically ill COVID-19 patients in Africa: it is time for quality registry data - Authors' reply.
Lancet. 2021;398:486-487.
PubMed

LEE N
Lucy Chappell: setting the agenda for UK research policy.
Lancet. 2021;398:481.
PubMed

DEVI S
Mediterranean migrants lacking health care.
Lancet. 2021;398:479-480.
PubMed

BLACK C
Treatment for drug dependence in England needs investment and reform.
Lancet. 2021;398:474-476.
PubMed

ROMANIS EC, Parsons JA, Salter I, Hampton T, et al
Safeguarding and teleconsultation for abortion.
Lancet. 2021;398:555-558.
PubMed

PISANI L, Waweru-Siika W, Sendagire C, Beane A, et al
Critically ill COVID-19 patients in Africa: it is time for quality registry data.
Lancet. 2021;398:485-486.
PubMed

DOLEZAL L, Rose A, Cooper F
COVID-19, online shaming, and health-care professionals.
Lancet. 2021;398:482-483.
PubMed

BELDA-INIESTA C
Optimising SARS-CoV-2 vaccination schedules.
Lancet. 2021 Aug 6. pii: S0140-6736(21)01729.
PubMed

LIU X, Shaw RH, Stuart ASV, Greenland M, et al
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Lancet. 2021 Aug 6. pii: S0140-6736(21)01694.
PubMed Abstract available

CHAUHAN K, Soni D, Sarkar D, Karuna T, et al
Mucormycosis after COVID-19 in a patient with diabetes.
Lancet. 2021 Aug 4. pii: S0140-6736(21)01641.
PubMed

July 2021

MATHUR R, Rentsch CT, Morton CE, Eggo RM, et al
Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply.
Lancet. 2021;398:390.
PubMed

PAN D, Martin CA, Nazareth J, Nevill CR, et al
Ethnic disparities in COVID-19: increased risk of infection or severe disease?
Lancet. 2021;398:389-390.
PubMed

LURIE N, Keusch GT, Dzau VJ
Should global financing be the main priority for pandemic preparedness? - Authors' reply.
Lancet. 2021;398:388-389.
PubMed

IJSSELMUIDEN C, Ntoumi F, Lavery JV, Montoya J, et al
Should global financing be the main priority for pandemic preparedness?
Lancet. 2021;398:388.
PubMed

THE LANCET
A sporting chance: physical activity as part of everyday life.
Lancet. 2021;398:365.
PubMed

KAMPMANN B, Okomo U
COVID-19 vaccines for children in LMICs: another equity issue.
Lancet. 2021 Jul 30. pii: S0140-6736(21)01748.
PubMed

MAFHAM M, Baigent C
What is the association of COVID-19 with heart attacks and strokes?
Lancet. 2021 Jul 29. pii: S0140-6736(21)01071.
PubMed

KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study.
Lancet. 2021 Jul 29. pii: S0140-6736(21)00896.
PubMed Abstract available

HORBY P, Staplin N, Haynes R, Landray M, et al
Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.
Lancet. 2021;398:300.
PubMed

YANG C, Zhao H
Tocilizumab in COVID-19 therapy: who benefits, and how?
Lancet. 2021;398:299.
PubMed

NEUMANN AU, Goekkaya M, Dorgham K, Traidl-Hoffmann C, et al
Tocilizumab in COVID-19 therapy: who benefits, and how?
Lancet. 2021;398:299-300.
PubMed

MARKS L
Past and present women pioneers in biomedical science.
Lancet. 2021;398:293-295.
PubMed

MAKONI M
Social unrest disrupts South African health care.
Lancet. 2021;398:287.
PubMed

REDJOUL R, Le Bouter A, Beckerich F, Fourati S, et al
Antibody response after second BNT162b2 dose in allogeneic HSCT recipients.
Lancet. 2021;398:298-299.
PubMed

THE LANCET
A time of crisis for the opioid epidemic in the USA.
Lancet. 2021;398:277.
PubMed

JAUREGUI A, Lambert EV, Panter J, Moore C, et al
Scaling up urban infrastructure for physical activity in the COVID-19 pandemic and beyond.
Lancet. 2021 Jul 21. pii: S0140-6736(21)01599.
PubMed

KENTOR RA, Thompson AL
Answering the call to support youth orphaned by COVID-19.
Lancet. 2021 Jul 20. pii: S0140-6736(21)01446.
PubMed

HILLIS SD, Unwin HJT, Chen Y, Cluver L, et al
Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study.
Lancet. 2021 Jul 20. pii: S0140-6736(21)01253.
PubMed Abstract available

DRAKE TM, Riad AM, Fairfield CJ, Egan C, et al
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
Lancet. 2021;398:223-237.
PubMed Abstract available

HARGREAVES S, Hayward SE, Noori T, McKee M, et al
COVID-19: counting migrants in.
Lancet. 2021;398:211-212.
PubMed

GU X, Cao B
In-hospital complications associated with COVID-19.
Lancet. 2021;398:188-190.
PubMed

IDROVO AJ
More social discontent than pandemic-related risk perception in Colombia.
Lancet. 2021;398:211.
PubMed

THE LANCET
COVID-19 in Africa: a lesson in solidarity.
Lancet. 2021;398:185.
PubMed

FISSEHA S, Sen G, Ghebreyesus TA, Byanyima W, et al
COVID-19: the turning point for gender equality.
Lancet. 2021 Jul 16. pii: S0140-6736(21)01651.
PubMed

HIAM L, Yates R
Will the COVID-19 crisis catalyse universal health reforms?
Lancet. 2021 Jul 16. pii: S0140-6736(21)01650.
PubMed

ABBAS K, Mogasale V
Disruptions to childhood immunisation due to the COVID-19 pandemic.
Lancet. 2021 Jul 14. pii: S0140-6736(21)01418.
PubMed

CAUSEY K, Fullman N, Sorensen RJD, Galles NC, et al
Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
Lancet. 2021 Jul 14. pii: S0140-6736(21)01337.
PubMed Abstract available

WHITE NJ, Strub-Wourgaft N, Faiz A, Guerin PJ, et al
WHO COVID-19 therapeutic guidelines - Authors' reply.
Lancet. 2021;398:118.
PubMed

ROCHWERG B, Agoritsas T, Diaz J, Askie L, et al
WHO COVID-19 therapeutic guidelines.
Lancet. 2021;398:117-118.
PubMed

ALSABA K
Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region.
Lancet. 2021;398:116.
PubMed

NABETH P, Hassan M, Adib K, Abubakar A, et al
Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region - Authors' reply.
Lancet. 2021;398:116-117.
PubMed

THE LANCET
COVID-19 in Latin America-emergency and opportunity.
Lancet. 2021;398:93.
PubMed

GARDNER C, Kleinman A
Medicine and the unconscious.
Lancet. 2021;398:112-113.
PubMed

LEHTIMAKI S, Allotey P, Schwalbe N
Pandemic response requires early and robust verification.
Lancet. 2021;398:115.
PubMed

TANRIOVER MD, Doganay HL, Akova M, Guner HR, et al
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
Lancet. 2021 Jul 8. pii: S0140-6736(21)01429.
PubMed Abstract available

GURDASANI D, Drury J, Greenhalgh T, Griffin S, et al
Mass infection is not an option: we must do more to protect our young.
Lancet. 2021 Jul 7. pii: S0140-6736(21)01589.
PubMed

CALISHER CH, Carroll D, Colwell R, Corley RB, et al
Science, not speculation, is essential to determine how SARS-CoV-2 reached humans.
Lancet. 2021 Jul 5. pii: S0140-6736(21)01419.
PubMed

PALMER KR, Tanner M, Davies-Tuck M, Rindt A, et al
Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.
Lancet. 2021;398:41-52.
PubMed Abstract available

CLARKE R
Sparks through the stubble: dying in a pandemic.
Lancet. 2021;398:18-19.
PubMed

THORNTON J
Levelling up health in the UK.
Lancet. 2021;398:14-15.
PubMed

DEVI S
North Korean health at risk due to border closures.
Lancet. 2021;398:13.
PubMed

THE LANCET
Germany's election: transformation versus more of the same.
Lancet. 2021;398:1.
PubMed

KICKBUSCH I, Leung GM, Shattock RJ
Learning from crisis: building resilient systems to combat future pandemics.
Lancet. 2021;398:e2-e6.
PubMed

MEYER NJ, Gattinoni L, Calfee CS
Acute respiratory distress syndrome.
Lancet. 2021 Jul 1. pii: S0140-6736(21)00439.
PubMed Abstract available

June 2021

WALL EC, Wu M, Harvey R, Kelly G, et al
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
Lancet. 2021 Jun 28. pii: S0140-6736(21)01462.
PubMed

KUMAR D, Mittal M
India's COVID-19 emergency: overarching conclusions belie facts.
Lancet. 2021;397:2465.
PubMed

SAHA K
Can India's COVID-19 emergency be fixed without politics?
Lancet. 2021;397:2465-2466.
PubMed

VISARIA A, Dharamdasani T
The complex causes of India's 2021 COVID-19 surge.
Lancet. 2021;397:2464.
PubMed

RADHAKRISHNAN N, Gupta DK
India's COVID-19 response: science first.
Lancet. 2021;397:2464-2465.
PubMed

DUTTA R, Kucchal T
India's pain: beyond COVID-19 case numbers and mortality rates.
Lancet. 2021;397:2463.
PubMed

DANIELS JP
Colombians protest over inequities and health care.
Lancet. 2021;397:2454.
PubMed

DUARTE-SALLES T, Prieto-Alhambra D
Heterologous vaccine regimens against COVID-19.
Lancet. 2021 Jun 25. pii: S0140-6736(21)01442.
PubMed

SMITH MJ
What constitutes success in the roll-out of COVID-19 vaccines?
Lancet. 2021 Jun 25. pii: S0140-6736(21)01244.
PubMed

BOROBIA AM, Carcas AJ, Perez-Olmeda M, Castano L, et al
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet. 2021 Jun 25. pii: S0140-6736(21)01420.
PubMed Abstract available

THE LANCET
Protecting refugees during the COVID-19 pandemic.
Lancet. 2021;397:2309.
PubMed

BARRON GC, Koonin J
A call to action on UHC commitments.
Lancet. 2021;397:2335-2336.
PubMed

USHER AD
A beautiful idea: how COVAX has fallen short.
Lancet. 2021;397:2322-2325.
PubMed

KC S, Ananthakrishnan A, Painter C, Butani D, et al
Research collaboration is needed to inform quarantine policies for health-care workers.
Lancet. 2021;397:2334.
PubMed

ABECASSIS A
Five priorities for universal COVID-19 vaccination.
Lancet. 2021 Jun 17. pii: S0140-6736(21)01371.
PubMed

SHEIKH A, McMenamin J, Taylor B, Robertson C, et al
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.
Lancet. 2021 Jun 14. pii: S0140-6736(21)01358.
PubMed

AMIT S, Regev-Yochay G, Afek A, Kreiss Y, et al
COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply.
Lancet. 2021;397:2249-2250.
PubMed

ROBERTSON JFR, Sewell HF
COVID-19 vaccine efficacy data: solid enough to delay second dose?
Lancet. 2021;397:2248-2249.
PubMed

VOYSEY M, Pollard AJ
ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.
Lancet. 2021;397:2248.
PubMed

MCQUADE ETR, Platts-Mills JA
ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates.
Lancet. 2021;397:2247-2248.
PubMed

NASSER A, Zakham F
A strategy for SARS-CoV-2 vaccination in Yemen.
Lancet. 2021;397:2247.
PubMed

GUBRIUM A, Gubrium E
Narrative complexity in the time of COVID-19.
Lancet. 2021;397:2244-2245.
PubMed

BERGER JS, Connors JM
Anticoagulation in COVID-19: reaction to the ACTION trial.
Lancet. 2021;397:2226-2228.
PubMed

MCLELLAN F
Kirsten Ostherr: mobilising the translational humanities.
Lancet. 2021;397:2243.
PubMed

THE LANCET
We need a global conversation on the 2020 Olympic Games.
Lancet. 2021;397:2225.
PubMed

GUETL K, Gary T, Raggam RB, Schmid J, et al
SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban.
Lancet. 2021 Jun 11. pii: S0140-6736(21)01238.
PubMed

EVAGORA-CAMPBELL M, Borkotoky K, Sharma S, Mbuthia M, et al
From routine data collection to policy design: sex and gender both matter in COVID-19.
Lancet. 2021 Jun 10. pii: S0140-6736(21)01326.
PubMed

BOLLYKY TJ, Murray CJL, Reiner RC Jr
Epidemiology, not geopolitics, should guide COVID-19 vaccine donations.
Lancet. 2021 Jun 8. pii: S0140-6736(21)01323.
PubMed

KUMAR A, Bernasconi V, Manak M, de Almeida Aranha AP, et al
The CEPI centralised laboratory network: supporting COVID-19 vaccine development.
Lancet. 2021;397:2148-2149.
PubMed

ZAROCOSTAS J
Aid agencies escalate Gaza relief effort.
Lancet. 2021;397:2136.
PubMed

BEYRER C
A pandemic anniversary: 40 years of HIV/AIDS.
Lancet. 2021;397:2142-2143.
PubMed

SHROFF ZC, Marten R, Vega J, Peters DH, et al
Time to reconceptualise health systems.
Lancet. 2021;397:2145.
PubMed

USHER AD
ACT Accelerator strains donors' aid budgets.
Lancet. 2021;397:2137.
PubMed

LOPES RD, de Barros E Silva PGM, Furtado RHM, Macedo AVS, et al
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
Lancet. 2021 Jun 4. pii: S0140-6736(21)01203.
PubMed Abstract available

CHAN EYY, Gobat N, Dubois C, Bedson J, et al
Bottom-up citizen engagement for health emergency and disaster risk management: directions since COVID-19.
Lancet. 2021 Jun 4. pii: S0140-6736(21)01233.
PubMed

KOSAKA M, Hashimoto T, Ozaki A, Tanimoto T, et al
Delayed COVID-19 vaccine roll-out in Japan.
Lancet. 2021 Jun 2. pii: S0140-6736(21)01220.
PubMed

NNAJI CA, Ndwandwe D, Lesosky M, Mahomed H, et al
Tackling missed opportunities for vaccination in a new era of immunisation.
Lancet. 2021 Jun 2. pii: S0140-6736(21)01226.
PubMed

May 2021

MAKONI M
Africa's need for more COVID-19 clinical trials.
Lancet. 2021;397:2037.
PubMed

TATUM M
Cambodia ends controversial COVID-19 restrictions.
Lancet. 2021;397:2035.
PubMed

DEVI S
Yemen's health system has "collapsed", warns UN.
Lancet. 2021;397:2036.
PubMed

DEVI S
800 000 South Sudanese to lose access to health care.
Lancet. 2021;397:2034.
PubMed

AIYAR Y, Chandru V, Chatterjee M, Desai S, et al
India's resurgence of COVID-19: urgent actions needed.
Lancet. 2021 May 25. pii: S0140-6736(21)01202.
PubMed

Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study.
Lancet. 2021;397:1885-1894.
PubMed Abstract available

JAWAD NK, Taweeleh LA, Elharake JA, Khamis N, et al
Refugee access to COVID-19 vaccines in Lebanon.
Lancet. 2021;397:1884.
PubMed

NESAMONEY SN, Darmstadt GL, Wise PH
Gendered effects of COVID-19 on young girls in regions of conflict.
Lancet. 2021;397:1880-1881.
PubMed

ZAROCOSTAS J
What next for a COVID-19 intellectual property waiver?
Lancet. 2021;397:1871-1872.
PubMed

KIRENGA BJ, Byakika-Kibwika P
Excess COVID-19 mortality among critically ill patients in Africa.
Lancet. 2021;397:1860-1861.
PubMed

MCGEORGE E, James J, Abraham N
The intergenerational project: creating space for play in health care.
Lancet. 2021;397:1876-1877.
PubMed

SAMARASEKERA U
Yee-Sin Leo: a leader in Singapore's fight against infectious diseases.
Lancet. 2021;397:1873.
PubMed

HUANG L, Gu X, Wang Y, Huang C, et al
Long-term effects of COVID-19 on kidney function - Authors' reply.
Lancet. 2021;397:1807-1808.
PubMed

WATSON SI
Global COVID-19 vaccine roll-out: time to randomise vaccine allocation?
Lancet. 2021;397:1804-1805.
PubMed

DELANAYE P, Huart J, Bouquegneau A, Jouret F, et al
Long-term effects of COVID-19 on kidney function.
Lancet. 2021;397:1807.
PubMed

ENGHARD P, Hardenberg JH, Stockmann H, Hinze C, et al
Long-term effects of COVID-19 on kidney function.
Lancet. 2021;397:1806-1807.
PubMed

LOYO ESL, Gonzalez MJ, Esparza J
Venezuela is collapsing without COVID-19 vaccines.
Lancet. 2021;397:1806.
PubMed

HOUSTON AR, Murthy S
Canada is no global health leader on COVID-19 vaccine equity.
Lancet. 2021;397:1803.
PubMed

GENC K
COVID-19 in Turkey: a nation on edge.
Lancet. 2021;397:1794-1796.
PubMed

HOLT E
Serbia begins paying citizens to receive a COVID-19 vaccine.
Lancet. 2021;397:1793.
PubMed

WENHAM C, Kavanagh M, Phelan A, Rushton S, et al
Problems with traffic light approaches to public health emergencies of international concern.
Lancet. 2021;397:1856-1858.
PubMed

HIMMELSTEIN DU, Woolhandler S
Recovering from Trump: Biden's first 100 days.
Lancet. 2021;397:1787-1791.
PubMed

LIU STH, Aberg JA
Convalescent plasma in patients hospitalised with COVID-19.
Lancet. 2021 May 14. pii: S0140-6736(21)01064.
PubMed

JHA P, Jamison DT, Watkins DA, Bell J, et al
A global compact to counter vaccine nationalism.
Lancet. 2021 May 14. pii: S0140-6736(21)01105.
PubMed

KUPPALLI K, Gala P, Cherabuddi K, Kalantri SP, et al
India's COVID-19 crisis: a call for international action.
Lancet. 2021 May 14. pii: S0140-6736(21)01121.
PubMed

MORGAN OW, Aguilera X, Ammon A, Amuasi J, et al
Disease surveillance for the COVID-19 era: time for bold changes.
Lancet. 2021 May 14. pii: S0140-6736(21)01096.
PubMed

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Lancet. 2021 May 14. pii: S0140-6736(21)00897.
PubMed Abstract available

LOGUNOV DY, Dolzhikova IV, Shcheblyakov DV
Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial - Authors' reply.
Lancet. 2021 May 12. pii: S0140-6736(21)00894.
PubMed

SHAW RH, Stuart A, Greenland M, Liu X, et al
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.
Lancet. 2021 May 12. pii: S0140-6736(21)01115.
PubMed

SIRLEAF EJ, Clark H
Report of the Independent Panel for Pandemic Preparedness and Response: making COVID-19 the last pandemic.
Lancet. 2021 May 11. pii: S0140-6736(21)01095.
PubMed

SHAH W, Heightman M, O'Brien S
UK guidelines for managing long-term effects of COVID-19.
Lancet. 2021;397:1706.
PubMed

MORALES DR, Ali SN
COVID-19 and disparities affecting ethnic minorities.
Lancet. 2021;397:1684-1685.
PubMed

FUJIWARA Y, Onda Y, Hayashi S
No-fault compensation schemes for COVID-19 medical products.
Lancet. 2021;397:1707-1708.
PubMed

HE S, Bala R, Anupindi R, Ranney ML, et al
Effective supply chain surveillance for PPE.
Lancet. 2021;397:1706-1707.
PubMed

DEVI S
COVID-19 surge threatens health in the Gaza strip.
Lancet. 2021;397:1698.
PubMed

THE LANCET
India's COVID-19 emergency.
Lancet. 2021;397:1683.
PubMed

MATHUR R, Rentsch CT, Morton CE, Hulme WJ, et al
Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform.
Lancet. 2021;397:1711-1724.
PubMed Abstract available

SAXENA SG, Godfrey T
Catalysing needed change for health systems in the USA.
Lancet. 2021;397:1705-1706.
PubMed

NASAR S
Patrolling race and the UK's medical borders.
Lancet. 2021;397:1702-1703.
PubMed

ZAROCOSTAS J
UK makes massive global health cuts.
Lancet. 2021;397:1697.
PubMed

HOLT E
Media restrictions have "cost lives".
Lancet. 2021;397:1695-1696.
PubMed

RICHTER L, Ghent L, Issa G, Okengo L, et al
What the ODA cuts mean for us.
Lancet. 2021;397:1705.
PubMed

REINHART E, Dawes D, Maybank A
Structural medicine: towards an economy of care.
Lancet. 2021;397:1691-1693.
PubMed

KIDD SA, Hajat S, Bezgrebelna M, McKenzie K, et al
The climate change-homelessness nexus.
Lancet. 2021;397:1693-1694.
PubMed

Priorities for COVID-19 research response and preparedness in low-resource settings.
Lancet. 2021 May 6. pii: S0140-6736(21)00980.
PubMed

ANDERSON M, Pitchforth E, Asaria M, Brayne C, et al
LSE-Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19.
Lancet. 2021 May 6. pii: S0140-6736(21)00232.
PubMed

CHARLESWORTH A, Anderson M, Donaldson C, Johnson P, et al
What is the right level of spending needed for health and care in the UK?
Lancet. 2021 May 6. pii: S0140-6736(21)00230.
PubMed Abstract available

ANDERSON M, O'Neill C, Macleod Clark J, Street A, et al
Securing a sustainable and fit-for-purpose UK health and care workforce.
Lancet. 2021 May 6. pii: S0140-6736(21)00231.
PubMed Abstract available

MCKEE M, Dunnell K, Anderson M, Brayne C, et al
The changing health needs of the UK population.
Lancet. 2021 May 6. pii: S0140-6736(21)00229.
PubMed Abstract available

LESHEM E, Wilder-Smith A
COVID-19 vaccine impact in Israel and a way out of the pandemic.
Lancet. 2021 May 5. pii: S0140-6736(21)01018.
PubMed

HAAS EJ, Angulo FJ, McLaughlin JM, Anis E, et al
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Lancet. 2021 May 5. pii: S0140-6736(21)00947.
PubMed Abstract available

GUPTA S, Leaf DE
Tocilizumab in COVID-19: some clarity amid controversy.
Lancet. 2021;397:1599-1601.
PubMed

BHUYAN A
Experts criticise India's complacency over COVID-19.
Lancet. 2021;397:1611-1612.
PubMed

FOGSTAD H
Women, children, and adolescents in the post-pandemic world.
Lancet. 2021;397:1620.
PubMed

HYDE R
Controversy surrounds Merkel's new lockdown powers.
Lancet. 2021;397:1610.
PubMed

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Lancet. 2021;397:1637-1645.
PubMed Abstract available

April 2021

OLIU-BARTON M, Pradelski BSR, Aghion P, Artus P, et al
SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties.
Lancet. 2021 Apr 28. pii: S0140-6736(21)00978.
PubMed

MAGNAVITA N, Chirico F, Sacco A
COVID-19: from hospitals to courts.
Lancet. 2021;397:1542.
PubMed

USUELLI M
COVID-19: from hospitals to courts - Author's reply.
Lancet. 2021;397:1542.
PubMed

PRIESEMANN V, Brinkmann MM, Ciesek S, Cuschieri S, et al
Call for a pan-European COVID-19 response must be comprehensive - Authors' reply.
Lancet. 2021;397:1541.
PubMed

KRUGER C
Call for a pan-European COVID-19 response must be comprehensive.
Lancet. 2021;397:1540-1541.
PubMed

BURKI T
Statelessness in the COVID-19 pandemic.
Lancet. 2021;397:1529-1530.
PubMed

THE LANCET
2021: the beginning of a new era of immunisations?
Lancet. 2021;397:1519.
PubMed

MARMOT M, Al-Mandhari A, Ghaffar A, El-Adawy M, et al
Build back fairer: achieving health equity in the Eastern Mediterranean region of WHO.
Lancet. 2021;397:1527-1528.
PubMed

RASANATHAN K
Global health and its discontents.
Lancet. 2021;397:1543-1544.
PubMed

DEAN N
Hospital admissions due to COVID-19 in Scotland after one dose of vaccine.
Lancet. 2021 Apr 23. pii: S0140-6736(21)00765.
PubMed

VASILEIOU E, Simpson CR, Shi T, Kerr S, et al
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.
Lancet. 2021 Apr 23. pii: S0140-6736(21)00677.
PubMed Abstract available

KHAN MS, Ali SAM, Adelaine A, Karan A, et al
Rethinking vaccine hesitancy among minority groups.
Lancet. 2021 Apr 21. pii: S0140-6736(21)00938.
PubMed

CLAESON M, Hanson S
The Swedish COVID-19 strategy revisited.
Lancet. 2021 Apr 19. pii: S0140-6736(21)00885.
PubMed

ALVES L
Brazilian ICUs short of drugs and beds amid COVID-19 surge.
Lancet. 2021;397:1431-1432.
PubMed

STOEKLE HC, Ivasilevitch A, Herve C
COVID-19: time for ethical reflection?
Lancet. 2021 Apr 16. pii: S0140-6736(21)00795.
PubMed

GREENHALGH T, Jimenez JL, Prather KA, Tufekci Z, et al
Ten scientific reasons in support of airborne transmission of SARS-CoV-2.
Lancet. 2021 Apr 15. pii: S0140-6736(21)00869.
PubMed

KADIWAR S, Smith JJ, Ledot S, Johnson M, et al
Were pregnant women more affected by COVID-19 in the second wave of the pandemic?
Lancet. 2021 Apr 14. pii: S0140-6736(21)00716.
PubMed

MFINANGA SG, Mnyambwa NP, Minja DT, Ntinginya NE, et al
Tanzania's position on the COVID-19 pandemic.
Lancet. 2021 Apr 14. pii: S0140-6736(21)00678.
PubMed

ZAROCOSTAS J
Calls for transparency after SARS-CoV-2 origins report.
Lancet. 2021;397:1335.
PubMed

THE LANCET
China's response to COVID-19: a chance for collaboration.
Lancet. 2021;397:1325.
PubMed

CAPUA I, Giaquinto C
The unsung virtue of thermostability.
Lancet. 2021;397:1346.
PubMed

CASSAN J, Claude A, de Hillerin M, Fontaine A, et al
The ultra-connected generation would like to disconnect now.
Lancet. 2021;397:1350.
PubMed

ANDREWS K
Racism is the public health crisis.
Lancet. 2021;397:1342-1343.
PubMed

KRAMMER F
Correlates of protection from SARS-CoV-2 infection.
Lancet. 2021 Apr 9. pii: S0140-6736(21)00782.
PubMed

HALL VJ, Foulkes S, Charlett A, Atti A, et al
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
Lancet. 2021 Apr 9. pii: S0140-6736(21)00675.
PubMed Abstract available

ALI SN, Hanif W, Patel K, Khunti K, et al
Ramadan and COVID-19 vaccine hesitancy-a call for action.
Lancet. 2021 Apr 7. pii: S0140-6736(21)00779.
PubMed

LOTTA G, Fernandez M, Pimenta D, Wenham C, et al
Gender, race, and health workers in the COVID-19 pandemic.
Lancet. 2021;397:1264.
PubMed

BOUM Y, Bebell LM, Bisseck AZ
Africa needs local solutions to face the COVID-19 pandemic.
Lancet. 2021;397:1238-1240.
PubMed

WONG CHUNG JERE, Engin O, Wolfs TFW, Renson TJC, et al
Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.
Lancet. 2021;397:e10.
PubMed

BOJORQUEZ I, Cabieses B, Arosquipa C, Arroyo J, et al
Migration and health in Latin America during the COVID-19 pandemic and beyond.
Lancet. 2021;397:1243-1245.
PubMed

SALYER SJ, Maeda J, Sembuche S, Kebede Y, et al
The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study.
Lancet. 2021;397:1265-1275.
PubMed Abstract available

HE S, Lai D, Lee J
The medical right to repair: the right to save lives.
Lancet. 2021;397:1260-1261.
PubMed

SAMARASEKERA U
New EU health programme comes into force.
Lancet. 2021;397:1252-1253.
PubMed

JABBOUR S, Leaning J, Nuwayhid I, Ager A, et al
10 years of the Syrian conflict: a time to act and not merely to remember.
Lancet. 2021;397:1245-1248.
PubMed

D'SOUZA RS, Wolfe I
COVID-19 vaccines in high-risk ethnic groups.
Lancet. 2021 Apr 1. pii: S0140-6736(21)00624.
PubMed

March 2021

EMARY KRW, Golubchik T, Aley PK, Ariani CV, et al
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
Lancet. 2021 Mar 30. pii: S0140-6736(21)00628.
PubMed Abstract available

SANDERS RW, de Jong MD
Pandemic moves and countermoves: vaccines and viral variants.
Lancet. 2021 Mar 30. pii: S0140-6736(21)00730.
PubMed

MYLAN S, Hardman C
COVID-19, cults, and the anti-vax movement.
Lancet. 2021;397:1181.
PubMed

THE LANCET
COVID-19: building a stronger Europe.
Lancet. 2021;397:1157.
PubMed

HIPGRAVE DB, Kampo A, Pearson L
Health systems in the ACT-A.
Lancet. 2021;397:1181-1182.
PubMed

NABETH P, Hassan M, Adib K, Abubakar A, et al
New COVID-19 resurgence in the WHO Eastern Mediterranean region.
Lancet. 2021 Mar 25. pii: S0140-6736(21)00679.
PubMed

KLUGE H, McKee M
COVID-19 vaccines for the European region: an unprecedented challenge.
Lancet. 2021 Mar 25. pii: S0140-6736(21)00709.
PubMed

Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights.
Lancet. 2021 Mar 24. pii: S0140-6736(21)00708.
PubMed

KARIM SSA
Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection.
Lancet. 2021 Mar 22. pii: S0140-6736(21)00468.
PubMed

MUNDT AP
Assessing government responsibility for COVID-19 deaths.
Lancet. 2021 Mar 22. pii: S0140-6736(21)00529.
PubMed

WHITE NJ, Strub-Wourgaft N, Faiz A, Guerin PJ, et al
Guidelines should not pool evidence from uncomplicated and severe COVID-19.
Lancet. 2021 Mar 22. pii: S0140-6736(21)00469.
PubMed

CHAKRABORTY D, Agrawal A, Maiti S
Rapid identification and tracking of SARS-CoV-2 variants of concern.
Lancet. 2021 Mar 22. pii: S0140-6736(21)00470.
PubMed

NKEREUWEM E, Kampmann B, Togun T
The need to prioritise childhood tuberculosis case detection.
Lancet. 2021 Mar 22. pii: S0140-6736(21)00672.
PubMed

STRUGNELL R, Wang N
Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2.
Lancet. 2021;397:1037-1039.
PubMed

GILL PS, Poduval S, Thakur JS, Iqbal R, et al
COVID-19, community trials, and inclusion.
Lancet. 2021;397:1036-1037.
PubMed

HE Z, Ren L, Yang J, Guo L, et al
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
Lancet. 2021;397:1075-1084.
PubMed Abstract available

JAFFE S
Biden's first legislative victory: $1.9 trillion for COVID-19.
Lancet. 2021;397:1047-1048.
PubMed

CRISP N
Human flourishing in a health-creating society.
Lancet. 2021;397:1054-1055.
PubMed

THE LANCET
Myanmar's democracy and health on life support.
Lancet. 2021;397:1035.
PubMed

BOZORGMEHR K, Jahn R, Stuckler D, McKee M, et al
Free licensing of vaccines to end the COVID-19 crisis.
Lancet. 2021 Mar 18. pii: S0140-6736(21)00467.
PubMed

BOYTON RJ, Altmann DM
Risk of SARS-CoV-2 reinfection after natural infection.
Lancet. 2021 Mar 17. pii: S0140-6736(21)00662.
PubMed

TURNER P, Montgomery H, Stroud M, Grimble G, et al
Malnutrition risk in hospitalised COVID-19 patients receiving CPAP.
Lancet. 2021 Mar 17. pii: S0140-6736(21)00447.
PubMed

KRIEGER N, Waterman PD, Chen JT, Testa C, et al
Missing again: US racial and ethnic data for COVID-19 vaccination.
Lancet. 2021 Mar 17. pii: S0140-6736(21)00465.
PubMed

SHAKESPEARE T, Ndagire F, Seketi QE
Triple jeopardy: disabled people and the COVID-19 pandemic.
Lancet. 2021 Mar 16. pii: S0140-6736(21)00625.
PubMed

HOLT E
Countries split from EU on COVID-19 vaccines.
Lancet. 2021;397:958.
PubMed

THE LANCET
Access to COVID-19 vaccines: looking beyond COVAX.
Lancet. 2021;397:941.
PubMed

AUCOTT JN, Rebman AW
Long-haul COVID: heed the lessons from other infection-triggered illnesses.
Lancet. 2021;397:967-968.
PubMed

COUSINS S
Australian Commission calls for overhaul of aged care.
Lancet. 2021;397:957.
PubMed

GURDASANI D, Alwan NA, Greenhalgh T, Hyde Z, et al
School reopening without robust COVID-19 mitigation risks accelerating the pandemic.
Lancet. 2021 Mar 10. pii: S0140-6736(21)00622.
PubMed

STEINBERG J, Thomas A, Iravani A
(18)Fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine.
Lancet. 2021 Mar 8. pii: S0140-6736(21)00464.
PubMed

HUNG IFN, Poland GA
Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster.
Lancet. 2021;397:854-855.
PubMed

USHER AD
Medical oxygen crisis: a belated COVID-19 response.
Lancet. 2021;397:868-869.
PubMed

SAMARASEKERA U
Robin Shattock: novel vaccine developer.
Lancet. 2021;397:870.
PubMed

SROUR SA
Social action to achieve a dignified life for people with disabilities in the occupied Palestinian territory.
Lancet. 2021;397:861-862.
PubMed

SOE ZW, Oo MM, Wah KS, Naing AT, et al
Myanmar's health leaders stand against military rule.
Lancet. 2021;397:875.
PubMed

MADAD S, Spencer C
The USA's response to the 2014 Ebola outbreak could have informed its COVID-19 response.
Lancet. 2021 Mar 5. pii: S0140-6736(21)00433.
PubMed

HEIDKAMP RA, Piwoz E, Gillespie S, Keats EC, et al
Mobilising evidence, data, and resources to achieve global maternal and child undernutrition targets and the Sustainable Development Goals: an agenda for action.
Lancet. 2021 Mar 5. pii: S0140-6736(21)00568.
PubMed Abstract available

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
Lancet. 2021 Mar 4. pii: S0140-6736(21)00461.
PubMed Abstract available

February 2021

CHAUVIN L
Peruvian COVID-19 vaccine scandal spreads.
Lancet. 2021;397:783.
PubMed

ZAROCOSTAS J
New WTO leader faces COVID-19 challenges.
Lancet. 2021;397:782.
PubMed

PEYRE M, Vourc'h G, Lefrancois T, Martin-Prevel Y, et al
PREZODE: preventing zoonotic disease emergence.
Lancet. 2021;397:792-793.
PubMed

MANISTY C, Otter AD, Treibel TA, McKnight A, et al
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.
Lancet. 2021 Feb 25. pii: S0140-6736(21)00501.
PubMed

PRENDECKI M, Clarke C, Brown J, Cox A, et al
Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.
Lancet. 2021 Feb 25. pii: S0140-6736(21)00502.
PubMed

WHITAKER DK
UK COVID-19 public inquiry and lessons from patient safety.
Lancet. 2021 Feb 24. pii: S0140-6736(21)00381.
PubMed

GODDARD AF, Patel M
The changing face of medical professionalism and the impact of COVID-19.
Lancet. 2021 Feb 23. pii: S0140-6736(21)00436.
PubMed

SIVA N
Severe mental illness: reassessing COVID-19 vaccine priorities.
Lancet. 2021;397:657.
PubMed

HYDE R
von der Leyen admits to COVID-19 vaccine failures.
Lancet. 2021;397:655-656.
PubMed

MMONU NA, Aifah A, Onakomaiya D, Ogedegbe G, et al
Why the global health community should support the EndSARS movement in Nigeria.
Lancet. 2021;397:666-667.
PubMed

DAS P
Sharrelle Barber: at the intersection of place, race, and health.
Lancet. 2021;397:659.
PubMed

THE LANCET
Health in the USA: under examination and under repair.
Lancet. 2021;397:641.
PubMed

VOYSEY M, Costa Clemens SA, Madhi SA, Weckx LY, et al
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Lancet. 2021 Feb 19. pii: S0140-6736(21)00432.
PubMed Abstract available

SISA I, Noblecilla E, Orozco F
Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs.
Lancet. 2021 Feb 19. pii: S0140-6736(21)00357.
PubMed

BERK J, Brinkley-Rubinstein L, Murphy M, Chan P, et al
MAb for symptomatic COVID-19 in correctional facilities: an important opportunity.
Lancet. 2021 Feb 19. pii: S0140-6736(21)00354.
PubMed

ROBERTSON JFR, Sewell HF, Stewart M
Delayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture?
Lancet. 2021 Feb 19. pii: S0140-6736(21)00455.
PubMed

AMIT S, Regev-Yochay G, Afek A, Kreiss Y, et al
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
Lancet. 2021 Feb 18. pii: S0140-6736(21)00448.
PubMed

FIELDS EL, Copeland R, Hopkins E
Same script, different viruses: HIV and COVID-19 in US Black communities.
Lancet. 2021 Feb 18. pii: S0140-6736(20)32522.
PubMed

KATES J, Dawson L, Horn TH, Killelea A, et al
Insurance coverage and financing landscape for HIV treatment and prevention in the USA.
Lancet. 2021 Feb 18. pii: S0140-6736(21)00397.
PubMed Abstract available

MAYER KH, Nelson L, Hightow-Weidman L, Mimiaga MJ, et al
The persistent and evolving HIV epidemic in American men who have sex with men.
Lancet. 2021 Feb 18. pii: S0140-6736(21)00321.
PubMed Abstract available

MINA MJ, Peto TE, Garcia-Finana M, Semple MG, et al
Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.
Lancet. 2021 Feb 17. pii: S0140-6736(21)00425.
PubMed

SKEGG D, Gluckman P, Boulton G, Hackmann H, et al
Future scenarios for the COVID-19 pandemic.
Lancet. 2021 Feb 16. pii: S0140-6736(21)00424.
PubMed

MAKONI M
Tanzania refuses COVID-19 vaccines.
Lancet. 2021;397:566.
PubMed

BERWANGER O
Azithromycin, RECOVERY, and the power of large, simple trials.
Lancet. 2021;397:559-560.
PubMed

SIVA N
New global initiative to tackle Alzheimer's disease.
Lancet. 2021;397:568-569.
PubMed

SINGH NS, Lokot M, Undie CC, Onyango MA, et al
Research in forced displacement: guidance for a feminist and decolonial approach.
Lancet. 2021;397:560-562.
PubMed

THE LANCET
Improving prisoner health for stronger public health.
Lancet. 2021;397:555.
PubMed

Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission.
Lancet. 2021 Feb 12. pii: S0140-6736(21)00388.
PubMed

WOUTERS OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, et al
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.
Lancet. 2021 Feb 12. pii: S0140-6736(21)00306.
PubMed Abstract available

FONTANET A, Autran B, Lina B, Kieny MP, et al
SARS-CoV-2 variants and ending the COVID-19 pandemic.
Lancet. 2021 Feb 11. pii: S0140-6736(21)00370.
PubMed

MARTIN S, Arawi T
Ensure Palestinians have access to COVID-19 vaccines.
Lancet. 2021 Feb 9. pii: S0140-6736(21)00190.
PubMed

BURKI T
Understanding variants of SARS-CoV-2.
Lancet. 2021;397:462.
PubMed

ZAROCOSTAS J
WHO team begins COVID-19 origin investigation.
Lancet. 2021;397:459.
PubMed

GORNA R, MacDermott N, Rayner C, O'Hara M, et al
Long COVID guidelines need to reflect lived experience.
Lancet. 2021;397:455-457.
PubMed

WARRELL MJ
Time to revise the strategy for Gavi funding of rabies vaccine?
Lancet. 2021;397:471-472.
PubMed

LANE R
Tahmeed Ahmed: new leader of icddr,b.
Lancet. 2021;397:463.
PubMed

THE LANCET
Genomic sequencing in pandemics.
Lancet. 2021;397:445.
PubMed

CLARFIELD AM, Skorecki K, Manor O, Glick S, et al
A COVID-19 jab in the right direction.
Lancet. 2021 Feb 4. pii: S0140-6736(21)00310.
PubMed

KAMPF G, Kulldorff M
Calling for benefit-risk evaluations of COVID-19 control measures.
Lancet. 2021 Feb 4. pii: S0140-6736(21)00193.
PubMed

MEREWOOD A, Bode L, Davanzo R, Perez-Escamilla R, et al
Breastfeed or be vaccinated-an unreasonable default recommendation.
Lancet. 2021 Feb 4. pii: S0140-6736(21)00197.
PubMed

JONES I, Roy P
Sputnik V COVID-19 vaccine candidate appears safe and effective.
Lancet. 2021 Feb 2. pii: S0140-6736(21)00191.
PubMed

LOGUNOV DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, et al
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.
Lancet. 2021 Feb 2. pii: S0140-6736(21)00234.
PubMed Abstract available

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Lancet. 2021 Feb 2. pii: S0140-6736(21)00149.
PubMed Abstract available

FRIESEN P, Caplan AL, Miller JE
COVID-19 vaccine research and the trouble with clinical equipoise.
Lancet. 2021 Feb 1. pii: S0140-6736(21)00198.
PubMed

TUYISENGE G, Goldenberg SM
COVID-19, structural racism, and migrant health in Canada.
Lancet. 2021 Feb 1. pii: S0140-6736(21)00215.
PubMed

January 2021

MUGUNGA JC, Tyagi K, Bernal-Serrano D, Correa N, et al
SARS-CoV-2 serosurveys in low-income and middle-income countries.
Lancet. 2021;397:353-355.
PubMed

SAMARASEKERA U
Fransisca Handy Agung: improving adolescent health in Indonesia.
Lancet. 2021;397:365.
PubMed

DANIELS JP
Health experts slam Bolsonaro's vaccine comments.
Lancet. 2021;397:361.
PubMed

THE LANCET
Health and care workers are owed a better future.
Lancet. 2021;397:347.
PubMed

HALLAL PC
SOS Brazil: science under attack.
Lancet. 2021;397:373-374.
PubMed

BLAKNEY AK, McKay PF
Next-generation COVID-19 vaccines: here come the proteins.
Lancet. 2021 Jan 29. pii: S0140-6736(21)00258.
PubMed

RICHMOND P, Hatchuel L, Dong M, Ma B, et al
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.
Lancet. 2021 Jan 29. pii: S0140-6736(21)00241.
PubMed Abstract available

WATT G, Giacaman R, Zurayk H, Bjertness E, et al
COVID-19 vaccines for Palestinians.
Lancet. 2021 Jan 28. pii: S0140-6736(21)00185.
PubMed

Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics.
Lancet. 2021 Jan 28. pii: S0140-6736(21)00242.
PubMed

SABINO EC, Buss LF, Carvalho MPS, Prete CA Jr, et al
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.
Lancet. 2021 Jan 27. pii: S0140-6736(21)00183.
PubMed

BARDAJI A, Sevene E, Cutland C, Menendez C, et al
The need for a global COVID-19 maternal immunisation research plan.
Lancet. 2021 Jan 25. pii: S0140-6736(21)00146.
PubMed

VON WEYHERN CH, Kaufmann I, Neff F, Kremer M, et al
Neuropathology associated with SARS-CoV-2 infection - Authors' reply.
Lancet. 2021;397:277-278.
PubMed

NASRALLAH MP, Mourelatos Z, Lee EB
Neuropathology associated with SARS-CoV-2 infection.
Lancet. 2021;397:277.
PubMed

GLATZEL M, Hagel C, Matschke J, Sperhake J, et al
Neuropathology associated with SARS-CoV-2 infection.
Lancet. 2021;397:276.
PubMed

EGERVARI K, Thomas C, Lobrinus JA, Kuhlmann T, et al
Neuropathology associated with SARS-CoV-2 infection.
Lancet. 2021;397:276-277.
PubMed

AGIUS RM, Kendrick D, Sewell HF, Stewart M, et al
Reaffirming health and safety precautionary principles for COVID-19 in the UK.
Lancet. 2021;397:274.
PubMed

MAKONI M
South Africa responds to new SARS-CoV-2 variant.
Lancet. 2021;397:267.
PubMed

BHUYAN A
India begins COVID-19 vaccination amid trial allegations.
Lancet. 2021;397:264.
PubMed

THE LANCET
COVID-19: the intersection of education and health.
Lancet. 2021;397:253.
PubMed

MARCHALIK D, Lipsky A
Transformative experiences and A Young Doctor's Notebook.
Lancet. 2021;397:270.
PubMed

JAFFE S
Rochelle Walensky: new Director of the US CDC.
Lancet. 2021;397:268.
PubMed

LAU E, Wang HH, Qiao J, Jiang B, et al
Wakley-Wu Lien Teh Prize Essay 2020: passing the baton to the next generation of health workers.
Lancet. 2021;397:261-262.
PubMed

PATEL MS, Phillips CB
COVID-19 and the moral imagination.
Lancet. 2021 Jan 22. pii: S0140-6736(21)00151.
PubMed

PRIESEMANN V, Balling R, Brinkmann MM, Ciesek S, et al
An action plan for pan-European defence against new SARS-CoV-2 variants.
Lancet. 2021 Jan 21. pii: S0140-6736(21)00150.
PubMed

IMPOUMA B, Mboussou F, Kasolo F, Yoti Z, et al
Preparing for a COVID-19 resurgence in the WHO African region.
Lancet. 2021 Jan 20. pii: S0140-6736(20)32725.
PubMed

DITTMAYER C, Meinhardt J, Radbruch H, Radke J, et al
Using EM data to understand COVID-19 pathophysiology - Authors' reply.
Lancet. 2021;397:197-198.
PubMed

DOLHNIKOFF M, Duarte-Neto AN, Saldiva PHN, Caldini EG, et al
Using EM data to understand COVID-19 pathophysiology.
Lancet. 2021;397:196-197.
PubMed

WEBSTER P
COVID-19 highlights Canada's care home crisis.
Lancet. 2021;397:183.
PubMed

LANE R
Anne Johnson: Dame of public health epidemiology.
Lancet. 2021;397:186.
PubMed

JAFFE S
New leadership at the US CDC.
Lancet. 2021;397:182.
PubMed

THE LANCET
An opportunity for American renewal.
Lancet. 2021;397:171.
PubMed

CAVALERI M, Enzmann H, Straus S, Cooke E, et al
The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines.
Lancet. 2021 Jan 13. pii: S0140-6736(21)00085.
PubMed

BARBARO RP, MacLaren G, Brodie D
ECMO support for COVID-19: a balancing act - Authors' reply.
Lancet. 2021;397:95.
PubMed

ZHANG Y, Ji B, Zhou Z
ECMO support for COVID-19: a balancing act.
Lancet. 2021;397:94-95.
PubMed

KUSIN S, Choo E
Parenting in the time of COVID-19.
Lancet. 2021;397:86.
PubMed

USHER AD
Health systems neglected by COVID-19 donors.
Lancet. 2021;397:83.
PubMed

KNEEBONE R, Schlegel C
Thinking across disciplinary boundaries in a time of crisis.
Lancet. 2021;397:89-90.
PubMed

COUSINS S
Polio in Afghanistan: a changing landscape.
Lancet. 2021;397:84-85.
PubMed

WATTS N, Amann M, Arnell N, Ayeb-Karlsson S, et al
The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises.
Lancet. 2021;397:129-170.
PubMed Abstract available

CORTINOVIS M, Perico N, Remuzzi G
Long-term follow-up of recovered patients with COVID-19.
Lancet. 2021 Jan 8. pii: S0140-6736(21)00039.
PubMed

HUANG C, Huang L, Wang Y, Li X, et al
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
Lancet. 2021 Jan 8. pii: S0140-6736(20)32656.
PubMed Abstract available

THE LANCET
Health as a foundation for society.
Lancet. 2021;397:1.
PubMed

DEVI S
2021: a year of humanitarian need.
Lancet. 2021;397:12-13.
PubMed

GOSTIN LO, Shalala DE, Hamburg MA, Bloom BR, et al
A global health action agenda for the Biden administration.
Lancet. 2021;397:5-8.
PubMed

KNIPPER M, Bozorgmehr K, Offe J, Orcutt M, et al
Germany's new global health strategy: leaving migrants behind.
Lancet. 2021;397:20-21.
PubMed

ROBERTS DE
Abolish race correction.
Lancet. 2021;397:17-18.
PubMed

ROCHON PA, Stall NM, Gurwitz JH
Making older women visible.
Lancet. 2021;397:21.
PubMed

December 2020

GOODMAN J, de Prudhoe K, Williams C
UK COVID-19 public inquiry needed to learn lessons and save lives.
Lancet. 2020 Dec 22. pii: S0140-6736(20)32726.
PubMed

CLAESON M, Hanson S
COVID-19 and the Swedish enigma.
Lancet. 2020 Dec 22. pii: S0140-6736(20)32750.
PubMed

HARMAN S, Herten-Crabb A, Morgan R, Smith J, et al
COVID-19 vaccines and women's security.
Lancet. 2020 Dec 22. pii: S0140-6736(20)32727.
PubMed

SAYAMPANATHAN AA, Heng CS, Pin PH, Pang J, et al
Infectivity of asymptomatic versus symptomatic COVID-19.
Lancet. 2020 Dec 18. pii: S0140-6736(20)32651.
PubMed

PRIESEMANN V, Brinkmann MM, Ciesek S, Cuschieri S, et al
Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections.
Lancet. 2020 Dec 18. pii: S0140-6736(20)32625.
PubMed

WOODHAMS C, Dacre J, Parnerkar I, Sharma M, et al
Pay gaps in medicine and the impact of COVID-19 on doctors' careers.
Lancet. 2020 Dec 15. pii: S0140-6736(20)32671.
PubMed

KUNG S, Doppen M, Black M, Hills T, et al
Reduced mortality in New Zealand during the COVID-19 pandemic.
Lancet. 2020 Dec 14. pii: S0140-6736(20)32647.
PubMed

FITZPATRICK MC, Pandey A, Wells CR, Sah P, et al
Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests.
Lancet. 2020 Dec 14. pii: S0140-6736(20)32635.
PubMed

BRAUN F, Edler C, Puelles VG, Huber TB, et al
Association of SARS-CoV-2 renal tropism with acute kidney injury - Authors' reply.
Lancet. 2020;396:1881-1882.
PubMed

CHOY KW
Association of SARS-CoV-2 renal tropism with acute kidney injury.
Lancet. 2020;396:1880-1881.
PubMed

LANGE B
Maintaining a gendered perspective in scientific meetings during the COVID-19 pandemic.
Lancet. 2020;396:1880.
PubMed

TOPOL EJ
Is my cough COVID-19?
Lancet. 2020;396:1874.
PubMed

SIVA N
Experts call to include prisons in COVID-19 vaccine plans.
Lancet. 2020;396:1870.
PubMed

THE LANCET
Facing up to long COVID.
Lancet. 2020;396:1861.
PubMed

BURGESS RA, Osborne RH, Yongabi KA, Greenhalgh T, et al
The COVID-19 vaccines rush: participatory community engagement matters more than ever.
Lancet. 2020 Dec 10. pii: S0140-6736(20)32642.
PubMed

KNOLL MD, Wonodi C
Oxford-AstraZeneca COVID-19 vaccine efficacy.
Lancet. 2020 Dec 8. pii: S0140-6736(20)32623.
PubMed

VOYSEY M, Clemens SAC, Madhi SA, Weckx LY, et al
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Lancet. 2020 Dec 8. pii: S0140-6736(20)32661.
PubMed Abstract available

USHER AD
South Africa and India push for COVID-19 patents ban.
Lancet. 2020;396:1790-1791.
PubMed

THE LANCET
An African plan to control COVID-19 is urgently needed.
Lancet. 2020;396:1777.
PubMed

MOLYNEUX DH, Eberhard ML, Cleaveland S, Addey R, et al
Certifying Guinea worm eradication: current challenges.
Lancet. 2020;396:1857-1860.
PubMed

BRIGGS ADM, Fraser C
Is NHS Test and Trace exacerbating COVID-19 inequalities?
Lancet. 2020 Dec 4. pii: S0140-6736(20)32593.
PubMed

THE LANCET
Climate and COVID-19: converging crises.
Lancet. 2020 Dec 2. pii: S0140-6736(20)32579.
PubMed

LAL A, Erondu NA, Heymann DL, Gitahi G, et al
Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage.
Lancet. 2020 Dec 1. pii: S0140-6736(20)32228.
PubMed Abstract available

November 2020

HERNANDEZ JM
SARS-CoV-2 risk misclassification explains poor COVID-19 management.
Lancet. 2020;396:1733-1734.
PubMed

FODJE T, Choo E
Applying for residency in the time of COVID-19.
Lancet. 2020;396:1718.
PubMed

COUSINS S
Afghanistan braced for second wave of COVID-19.
Lancet. 2020;396:1716-1717.
PubMed

THE LANCET
Maintaining the HIV response in a world shaped by COVID-19.
Lancet. 2020;396:1703.
PubMed

GOGA A, Bekker LG, Van de Perre P, El-Sadr W, et al
Centring adolescent girls and young women in the HIV and COVID-19 responses.
Lancet. 2020 Nov 27. pii: S0140-6736(20)32552.
PubMed

BEYRER C, Sullivan P, Adimora AA, Mayer K, et al
HIV in the USA: priorities for the new administration.
Lancet. 2020 Nov 27. pii: S0140-6736(20)32524.
PubMed

HILLS T, Kearns N, Kearns C, Beasley R, et al
Influenza control during the COVID-19 pandemic.
Lancet. 2020;396:1633-1634.
PubMed

THE LANCET
COVID-19 vaccines: no time for complacency.
Lancet. 2020;396:1607.
PubMed

GRIFFITHS C, Mitchell M, Burnand A
More support needed for UK charity-funded medical research.
Lancet. 2020;396:1616-1618.
PubMed

AL-MANDHARI AS, Brennan RJ, Abubakar A, Hajjeh R, et al
Tackling COVID-19 in the Eastern Mediterranean Region.
Lancet. 2020 Nov 19. pii: S0140-6736(20)32349.
PubMed

MATHUR R, Bear L, Khunti K, Eggo RM, et al
Urgent actions and policies needed to address COVID-19 among UK ethnic minorities.
Lancet. 2020 Nov 19. pii: S0140-6736(20)32465.
PubMed

RAMASAMY MN, Minassian AM, Ewer KJ, Flaxman AL, et al
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Lancet. 2020 Nov 18. pii: S0140-6736(20)32466.
PubMed Abstract available

STEFANICK ML, Schiebinger L
Analysing how sex and gender interact.
Lancet. 2020;396:1553-1554.
PubMed

CHANDAN JS
Improving global surveillance of gender-based violence.
Lancet. 2020;396:1562.
PubMed

AL KNAWY B, Adil M, Crooks G, Rhee K, et al
The Riyadh Declaration: the role of digital health in fighting pandemics.
Lancet. 2020;396:1537-1539.
PubMed

SHAW A, Flott K, Fontana G, Durkin M, et al
No patient safety without health worker safety.
Lancet. 2020;396:1541-1543.
PubMed

MOLLICA RF, Fernando D
When racial trauma is a chief complaint among health-care staff.
Lancet. 2020;396:e84.
PubMed

CASTRO A
Maternal and child mortality worsens in Latin America and the Caribbean.
Lancet. 2020;396:e85.
PubMed

FORE HH, Ghebreyesus TA, Watkins K, Greenslade L, et al
Leveraging the COVID-19 response to end preventable child deaths from pneumonia.
Lancet. 2020 Nov 11. pii: S0140-6736(20)32348.
PubMed

ZIMERMAN A, Lopes RD, D'Avila A, Rohde LE, et al
COVID-19 in Brazil: the headlines should be about science.
Lancet. 2020 Nov 10. pii: S0140-6736(20)32375.
PubMed

GURDASANI D, Bear L, Bogaert D, Burgess RA, et al
The UK needs a sustainable strategy for COVID-19.
Lancet. 2020 Nov 9. pii: S0140-6736(20)32350.
PubMed

KRIEGER N, Testa C, Hanage WP, Chen JT, et al
US racial and ethnic data for COVID-19 cases: still missing in action.
Lancet. 2020;396:e81.
PubMed

COVIDSURG COLLABORATIVE
Surgery during the COVID-19 pandemic - Authors' reply.
Lancet. 2020;396:e79.
PubMed

VUTHALURU S, Koliyadan SV, Kanniwadi SS
Surgery during the COVID-19 pandemic.
Lancet. 2020;396:e78.
PubMed

MEECHAM L, Shakarchi JA, Rahman HP, Nyamekye IK, et al
Surgery during the COVID-19 pandemic.
Lancet. 2020;396:e77.
PubMed

ALDERMAN J
Surgery during the COVID-19 pandemic.
Lancet. 2020;396:e76.
PubMed

RODRIGUES J, Chan JK, Issa F
Surgery during the COVID-19 pandemic.
Lancet. 2020;396:e75.
PubMed

SHANTHANNA H, Uppal V
Surgery during the COVID-19 pandemic.
Lancet. 2020;396:e74.
PubMed

HAMID HKS
Surgery during the COVID-19 pandemic.
Lancet. 2020;396:e73.
PubMed

HUNG IF, Yuen KY
Early triple antiviral therapy for COVID-19 - Authors' reply.
Lancet. 2020;396:1488.
PubMed

LEE N, Ison M, Dunning J
Early triple antiviral therapy for COVID-19.
Lancet. 2020;396:1487-1488.
PubMed

VOYSEY M, Pollard AJ
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
Lancet. 2020;396:1486-1487.
PubMed

LODGE A
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
Lancet. 2020;396:1486.
PubMed

CHAUHAN A, Agarwal A, Jaiswal N, Singh M, et al
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
Lancet. 2020;396:1485-1486.
PubMed

HOFFMANN C, Wolf E
SARS-CoV-2 seroprevalence in Spain.
Lancet. 2020;396:1484.
PubMed

POLLAN M, Perez-Gomez B, Pastor-Barriuso R, Oteo J, et al
SARS-CoV-2 seroprevalence in Spain - Authors' reply.
Lancet. 2020;396:1484-1485.
PubMed

GEORGE TP
SARS-CoV-2 seroprevalence in Spain.
Lancet. 2020;396:1484.
PubMed

DZAU VJ, Balatbat C
Strategy, coordinated implementation, and sustainable financing needed for COVID-19 innovations.
Lancet. 2020;396:1469-1471.
PubMed

THE LANCET
COVID-19 in Latin America: a humanitarian crisis.
Lancet. 2020;396:1463.
PubMed

BHADORIA AS, Gawande K, Sharma R, Mohapatra A, et al
Institutional versus home isolation to curb the COVID-19 outbreak.
Lancet. 2020 Nov 6. pii: S0140-6736(20)32161.
PubMed

WILDER-SMITH A, Cook AR, Dickens BL
Institutional versus home isolation to curb the COVID-19 outbreak - Authors' reply.
Lancet. 2020 Nov 6. pii: S0140-6736(20)32171.
PubMed

ANDERSON RM, Vegvari C, Truscott J, Collyer BS, et al
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.
Lancet. 2020 Nov 4. pii: S0140-6736(20)32318.
PubMed

HOPKINS C, Smith B
Widespread smell testing for COVID-19 has limited application.
Lancet. 2020 Nov 3. pii: S0140-6736(20)32317.
PubMed

MENNI C, Sudre CH, Steves CJ, Ourselin S, et al
Widespread smell testing for COVID-19 has limited application - Authors' reply.
Lancet. 2020 Nov 3. pii: S0140-6736(20)32316.
PubMed

October 2020

OKELL LC, Verity R, Katzourakis A, Volz EM, et al
Host or pathogen-related factors in COVID-19 severity? - Authors' reply.
Lancet. 2020;396:1397.
PubMed

GORTAZAR C, Del-Rio FJR, Dominguez L, de la Fuente J, et al
Host or pathogen-related factors in COVID-19 severity?
Lancet. 2020;396:1396-1397.
PubMed

QU Z, Oedingen C, Bartling T, Schrem H, et al
Organ procurement and transplantation in Germany during the COVID-19 pandemic.
Lancet. 2020;396:1395.
PubMed

REDDY S, Dumbill R, Akhtar MZ, Udupa V, et al
Transplant programmes in areas with high SARS-CoV-2 transmission.
Lancet. 2020;396:1395-1396.
PubMed

TREIBEL TA, Manisty C, Andiapen M, Pade C, et al
Asymptomatic health-care worker screening during the COVID-19 pandemic - Authors' reply.
Lancet. 2020;396:1394-1395.
PubMed

CHOW A, Htun HL, Kyaw WM, Lee LT, et al
Asymptomatic health-care worker screening during the COVID-19 pandemic.
Lancet. 2020;396:1393-1394.
PubMed

FENNELLY K, Whalen CC
Asymptomatic health-care worker screening during the COVID-19 pandemic.
Lancet. 2020;396:1393.
PubMed

HOLT E
Slovakia to test all adults for SARS-CoV-2.
Lancet. 2020;396:1386-1387.
PubMed

FREUDENTHAL R, Horowitz M, Jadhav S, Moncrieff J, et al
Lack of safeguards in response to restrictive public health measures.
Lancet. 2020;396:e70.
PubMed

KRAUSE PR, Fleming TR, Ellenberg SS, Henao-Restrepo AM, et al
Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential.
Lancet. 2020 Oct 27. pii: S0140-6736(20)32259.
PubMed

FERIGATO S, Fernandez M, Amorim M, Ambrogi I, et al
The Brazilian Government's mistakes in responding to the COVID-19 pandemic.
Lancet. 2020 Oct 20. pii: S0140-6736(20)32164.
PubMed

STEWART R, El-Harakeh A, Cherian SA
Evidence synthesis communities in low-income and middle-income countries and the COVID-19 response.
Lancet. 2020 Oct 20. pii: S0140-6736(20)32141.
PubMed

BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
Use of adenovirus type-5 vectored vaccines: a cautionary tale.
Lancet. 2020 Oct 19. pii: S0140-6736(20)32156.
PubMed

PAES-SOUSA R, Millett C, Rocha R, Barreto ML, et al
Science misuse and polarised political narratives in the COVID-19 response.
Lancet. 2020 Oct 19. pii: S0140-6736(20)32168.
PubMed

THE LANCET
Global health: time for radical change?
Lancet. 2020;396:1129.
PubMed

PETO J, Hunter DJ, Riboli E, Griffin JL, et al
Unnecessary obstacles to COVID-19 mass testing.
Lancet. 2020 Oct 16. pii: S0140-6736(20)32170.
PubMed

ALWAN NA, Burgess RA, Ashworth S, Beale R, et al
Scientific consensus on the COVID-19 pandemic: we need to act now.
Lancet. 2020 Oct 15. pii: S0140-6736(20)32153.
PubMed

USUELLI M
The Lombardy region of Italy launches the first investigative COVID-19 commission.
Lancet. 2020 Oct 15. pii: S0140-6736(20)32154.
PubMed

WARD BJ, Makarkov A, Seguin A, Pillet S, et al
Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18-64 years) and older adults (>/=65 years): two multicentre, randomised phase 3 trials.
Lancet. 2020 Oct 13. pii: S0140-6736(20)32014.
PubMed Abstract available

TREGONING JS
First human efficacy study of a plant-derived influenza vaccine.
Lancet. 2020 Oct 13. pii: S0140-6736(20)32010.
PubMed

POLAND GA, Ovsyannikova IG, Kennedy RB
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.
Lancet. 2020 Oct 13. pii: S0140-6736(20)32137.
PubMed Abstract available

HONIGSBAUM M, Krishnan L
Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers.
Lancet. 2020 Oct 12. pii: S0140-6736(20)32134.
PubMed

BLUKACZ A, Cabieses B
COVID-19: leaving no one behind in Latin America.
Lancet. 2020;396:1070.
PubMed

CHARLIER P, Varison L
Is COVID-19 being used as a weapon against Indigenous Peoples in Brazil?
Lancet. 2020;396:1069-1070.
PubMed

KUDERER NM, Wulff-Burchfield E, Rubinstein SM, Grivas P, et al
Cancer and COVID-19 - Authors' reply.
Lancet. 2020;396:1067-1068.
PubMed

MALEK AE, Raad II, Jabbour E
Cancer and COVID-19.
Lancet. 2020;396:1066-1067.
PubMed

MORIS D, Tsilimigras DI, Schizas D
Cancer and COVID-19.
Lancet. 2020;396:1066.
PubMed

GROSS R, Conzelmann C, Muller JA, Reister F, et al
Undermining breastfeeding will not alleviate the COVID-19 pandemic - Authors' reply.
Lancet. 2020;396:1065-1066.
PubMed

CUMMINGS MJ, O'Donnell MR
Study of critically ill patients with COVID-19 in New York City - Authors' reply.
Lancet. 2020;396:1064.
PubMed

SHENKER NS, Wesolowska A, van Goudoever JB, Nangia S, et al
Undermining breastfeeding will not alleviate the COVID-19 pandemic.
Lancet. 2020;396:1064-1065.
PubMed

PIOVANI D, Bonovas S
Study of critically ill patients with COVID-19 in New York City.
Lancet. 2020;396:1064.
PubMed

CALLENDER B, Obuobi S, Czerwiec MK, Williams I, et al
COVID-19, comics, and the visual culture of contagion.
Lancet. 2020;396:1061-1063.
PubMed

COUSINS S
2.5 million more child marriages due to COVID-19 pandemic.
Lancet. 2020;396:1059.
PubMed

THE LANCET
Mental health: time to invest in quality.
Lancet. 2020;396:1045.
PubMed

FRUMKIN H, Myers SS
Planetary health and the 2020 US election.
Lancet. 2020;396:1048-1050.
PubMed

ALLOTEY P, Denton F
Challenges and priorities for delivering on the Beijing Declaration and Platform for Action 25 years on.
Lancet. 2020;396:1053-1055.
PubMed

CARLET J, Payen D, Opal SM
Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.
Lancet. 2020 Oct 9. pii: S0140-6736(20)32132.
PubMed

VAN TULLEKEN C, Wright C, Brown A, McCoy D, et al
Marketing of breastmilk substitutes during the COVID-19 pandemic.
Lancet. 2020 Oct 8. pii: S0140-6736(20)32119.
PubMed

BEDFORD J, Enria D, Giesecke J, Heymann DL, et al
Living with the COVID-19 pandemic: act now with the tools we have.
Lancet. 2020 Oct 8. pii: S0140-6736(20)32117.
PubMed

DITTMAYER C, Meinhardt J, Radbruch H, Radke J, et al
Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral.
Lancet. 2020 Oct 5. pii: S0140-6736(20)32079.
PubMed

BOZORGMEHR K
Power of and power over COVID-19 response guidelines.
Lancet. 2020 Oct 5. pii: S0140-6736(20)32081.
PubMed

CAO B, Hayden FG
Antiviral monotherapy for hospitalised patients with COVID-19 is not enough.
Lancet. 2020 Oct 5. pii: S0140-6736(20)32078.
PubMed

Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Lancet. 2020 Oct 5. pii: S0140-6736(20)32013.
PubMed Abstract available

DENING KH, Lloyd-Williams M
Minimising long-term effect of COVID-19 in dementia care.
Lancet. 2020;396:957-958.
PubMed

WANG Y, Gu X, Xu J, Cao B, et al
Remdesivir and COVID-19 - Authors' reply.
Lancet. 2020;396:954.
PubMed

WANG LY, Cui JJ, Ouyang QY, Zhan Y, et al
Remdesivir and COVID-19.
Lancet. 2020;396:953-954.
PubMed

EDWARDS JK, Cole SR, Adimora AA
Remdesivir and COVID-19.
Lancet. 2020;396:953.
PubMed

GLAUS MJ, Von Ruden S
Remdesivir and COVID-19.
Lancet. 2020;396:952.
PubMed

MCMAHON JH, Hoy JF, Kamarulzaman A, Bekker LG, et al
Leveraging the advances in HIV for COVID-19.
Lancet. 2020;396:943-944.
PubMed

THE LANCET
Building a resilient NHS, for COVID-19 and beyond.
Lancet. 2020;396:935.
PubMed

September 2020

CAUCHEMEZ S, Kiem CT, Paireau J, Rolland P, et al
Lockdown impact on COVID-19 epidemics in regions across metropolitan France.
Lancet. 2020 Sep 29. pii: S0140-6736(20)32034.
PubMed

STRATHDEE SA, Davies SC, Marcelin JR
Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election.
Lancet. 2020 Sep 29. pii: S0140-6736(20)32063.
PubMed

LASRY A, Horth R
Models for mortality require tailoring in the context of the COVID-19 pandemic.
Lancet. 2020;396:883.
PubMed

BANERJEE A, Pasea L, Denaxas S, Williams B, et al
Models for mortality require tailoring in the context of the COVID-19 pandemic - Authors' reply.
Lancet. 2020;396:883-884.
PubMed

HAGAY Z
Israeli aid to the West Bank and the Gaza Strip during the COVID-19 pandemic.
Lancet. 2020;396:882.
PubMed

JAFFE S
Media reports reveal political interference at the US CDC.
Lancet. 2020;396:875.
PubMed

THE LANCET
COVID-19 in India: the dangers of false optimism.
Lancet. 2020;396:867.
PubMed

BALL P
David Hare's fiery account of COVID-19.
Lancet. 2020;396:878-879.
PubMed

BARBARO RP, MacLaren G, Boonstra PS, Iwashyna TJ, et al
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.
Lancet. 2020 Sep 25. pii: S0140-6736(20)32008.
PubMed Abstract available

FLOWER B, Atchison C
SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA.
Lancet. 2020 Sep 25. pii: S0140-6736(20)32006.
PubMed

ANAND S, Montez-Rath M, Han J, Bozeman J, et al
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.
Lancet. 2020 Sep 25. pii: S0140-6736(20)32009.
PubMed Abstract available

HAN E, Tan MMJ, Turk E, Sridhar D, et al
Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe.
Lancet. 2020 Sep 24. pii: S0140-6736(20)32007.
PubMed Abstract available

LOGUNOV DY, Dolzhikova IV, Tukhvatullin AI, Shcheblyakov DV, et al
Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
Lancet. 2020 Sep 21. pii: S0140-6736(20)31970.
PubMed

BUCCI E, Andreev K, Bjorkman A, Calogero RA, et al
Safety and efficacy of the Russian COVID-19 vaccine: more information needed.
Lancet. 2020 Sep 21. pii: S0140-6736(20)31960.
PubMed

PEIRIS M, Leung GM
What can we expect from first-generation COVID-19 vaccines?
Lancet. 2020 Sep 21. pii: S0140-6736(20)31976.
PubMed

AGREN D
Understanding Mexican health worker COVID-19 deaths.
Lancet. 2020;396:807.
PubMed

KLEINERT S, Horton R
Preprints with The Lancet are here to stay.
Lancet. 2020;396:805.
PubMed

JONES D, Helmreich S
A history of herd immunity.
Lancet. 2020;396:810-811.
PubMed

GALEA S, Ettman CK, Abdalla SM
Access to health care and the 2020 US election.
Lancet. 2020;396:803-805.
PubMed

Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly.
Lancet. 2020 Sep 14. pii: S0140-6736(20)31927.
PubMed

SLIWA K, Yacoub M
Catalysing the response to NCDI Poverty at a time of COVID-19.
Lancet. 2020 Sep 14. pii: S0140-6736(20)31911.
PubMed

THE LANCET
Global collaboration for health: rhetoric versus reality.
Lancet. 2020;396:735.
PubMed

OLDENBURG CE, Doan T
Azithromycin for severe COVID-19.
Lancet. 2020 Sep 4. pii: S0140-6736(20)31863.
PubMed

FURTADO RHM, Berwanger O, Fonseca HA, Correa TD, et al
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
Lancet. 2020 Sep 4. pii: S0140-6736(20)31862.
PubMed Abstract available

BAR-ZEEV N, Inglesby T
COVID-19 vaccines: early success and remaining challenges.
Lancet. 2020 Sep 3. pii: S0140-6736(20)31867.
PubMed

LOGUNOV DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, et al
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
Lancet. 2020 Sep 3. pii: S0140-6736(20)31866.
PubMed Abstract available

August 2020

FISHER DA, Carson G
Back to basics: the outbreak response pillars.
Lancet. 2020;396:598.
PubMed

April 2020

CHENG KK, Lam TH, Leung CC
Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity.
Lancet. 2020 Apr 16. pii: S0140-6736(20)30918.
PubMed

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.